| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 ADGRE2 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 TAS2R50 OR4K3 | 3.21e-53 | 884 | 165 | 72 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPR3 CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TMEM63B LGR4 TAAR2 TAAR3P CCRL2 GRID1 GPR63 RXFP3 ADGRE2 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 OR6M1 IFNLR1 EDNRA CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 ABCC8 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 TAS2R50 OR4K3 | 6.02e-47 | 1353 | 165 | 78 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 TAAR2 TAAR3P ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 TAAR9 | 2.14e-27 | 41 | 165 | 18 | GO:0008227 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | NPY1R MCHR1 GPR32 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 RXFP3 SSTR5 GRPR EDNRA OPRL1 OXTR RXFP2 MRGPRX4 RXFP1 | 3.30e-21 | 133 | 165 | 21 | GO:0008528 |
| GeneOntologyMolecularFunction | peptide receptor activity | NPY1R MCHR1 GPR32 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 RXFP3 SSTR5 GRPR EDNRA OPRL1 OXTR RXFP2 MRGPRX4 RXFP1 | 1.01e-20 | 140 | 165 | 21 | GO:0001653 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC3 ABCC1 CHRNA6 SLC22A25 HTR1B SLC4A7 ABCA13 SLC5A7 TMEM63B GRID1 GRM7 SLCO6A1 ABCA9 CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC17A9 MLC1 SLC20A1 KCNJ2 ABCC8 SLC16A14 SLC6A5 OTOP1 ABCB11 SLC13A5 TMC5 SLC41A1 SLC44A3 | 5.96e-17 | 1180 | 165 | 43 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ABCC3 ABCC1 CHRNA6 SLC22A25 HTR1B SLC4A7 ABCA13 SLC5A7 TMEM63B GRID1 GRM7 SLCO6A1 ABCA9 CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC17A9 MLC1 SLC20A1 KCNJ2 ABCC8 SLC16A14 SLC6A5 OTOP1 ABCB11 SLC13A5 TMC5 SLC41A1 SLC44A3 | 1.42e-15 | 1289 | 165 | 43 | GO:0005215 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GRID1 GRM5 CHRNB2 ADRB1 HRH4 | 4.14e-15 | 100 | 165 | 15 | GO:0030594 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CHRNA6 HTR1B SLC4A7 SLC5A7 TMEM63B GRID1 GRM7 CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 MLC1 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 TMC5 SLC41A1 | 1.17e-14 | 793 | 165 | 33 | GO:0015075 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | HTR1B SLC4A7 SLC5A7 GRM7 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 SLC13A5 SLC41A1 | 1.24e-14 | 465 | 165 | 26 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CHRNA6 HTR1B SLC4A7 SLC5A7 TMEM63B GRM7 CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 | 2.64e-14 | 664 | 165 | 30 | GO:0008324 |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 2.72e-13 | 10 | 165 | 7 | GO:0004935 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | HTR1B SLC4A7 SLC5A7 TMEM63B GRM7 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 | 2.85e-13 | 627 | 165 | 28 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC3 ABCC1 HTR1B SLC4A7 SLC5A7 TMEM63B GRM7 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 KCNA2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 | 8.09e-13 | 758 | 165 | 30 | GO:0015318 |
| GeneOntologyMolecularFunction | hormone binding | DRD4 MCHR1 GPER1 AVPR1A MC3R ECE1 ADRA2A ADRA2B ADRB3 OXTR RXFP2 MTNR1A RXFP1 | 2.92e-12 | 103 | 165 | 13 | GO:0042562 |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 5.31e-12 | 22 | 165 | 8 | GO:0004993 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC3 ABCC1 SLC22A25 SLC4A7 ABCA13 SLC5A7 SLCO6A1 ABCA9 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC17A9 SLC20A1 ABCC8 SLC16A14 SLC6A5 ABCB11 SLC13A5 SLC41A1 | 1.00e-11 | 477 | 165 | 23 | GO:0022804 |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 4.95e-11 | 28 | 165 | 8 | GO:0005251 | |
| GeneOntologyMolecularFunction | gated channel activity | CHRNA6 HTR1B TMEM63B GRID1 GRM7 CHRNB2 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 TMC5 | 3.53e-10 | 334 | 165 | 18 | GO:0022836 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | HTR1B GRM7 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 4.22e-10 | 152 | 165 | 13 | GO:0022843 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC22A25 SLC4A7 SLC5A7 SLCO6A1 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC17A9 SLC20A1 SLC16A14 SLC6A5 SLC13A5 SLC41A1 | 4.23e-10 | 296 | 165 | 17 | GO:0015291 |
| GeneOntologyMolecularFunction | catecholamine binding | 4.75e-10 | 13 | 165 | 6 | GO:1901338 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.77e-10 | 37 | 165 | 8 | GO:0042923 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 8.17e-10 | 102 | 165 | 11 | GO:0005249 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CHRNA6 HTR1B TMEM63B GRID1 GRM7 CHRNB2 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 MLC1 KCNJ2 ABCC8 OTOP1 TMC5 | 1.45e-09 | 459 | 165 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | HTR1B GRM7 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 3.88e-09 | 182 | 165 | 13 | GO:0005244 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CHRNA6 HTR1B TMEM63B GRM7 CHRNB2 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 OTOP1 | 3.97e-09 | 343 | 165 | 17 | GO:0005261 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | HTR1B GRM7 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 4.43e-09 | 184 | 165 | 13 | GO:0022832 |
| GeneOntologyMolecularFunction | norepinephrine binding | 4.50e-09 | 4 | 165 | 4 | GO:0051380 | |
| GeneOntologyMolecularFunction | potassium channel activity | KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 9.28e-09 | 128 | 165 | 11 | GO:0005267 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.14e-08 | 75 | 165 | 9 | GO:0098960 | |
| GeneOntologyMolecularFunction | channel activity | CHRNA6 HTR1B TMEM63B GRID1 GRM7 CHRNB2 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 MLC1 KCNJ2 ABCC8 OTOP1 TMC5 | 1.41e-08 | 525 | 165 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | amine binding | 1.42e-08 | 21 | 165 | 6 | GO:0043176 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CHRNA6 HTR1B TMEM63B GRID1 GRM7 CHRNB2 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 MLC1 KCNJ2 ABCC8 OTOP1 TMC5 | 1.45e-08 | 526 | 165 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | KCNK18 SLC9A4 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 1.47e-08 | 167 | 165 | 12 | GO:0015079 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC4A7 SLC5A7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC20A1 SLC6A5 SLC13A5 SLC41A1 | 1.92e-08 | 171 | 165 | 12 | GO:0015081 |
| GeneOntologyMolecularFunction | serotonin binding | 4.42e-08 | 13 | 165 | 5 | GO:0051378 | |
| GeneOntologyMolecularFunction | epinephrine binding | 6.66e-08 | 6 | 165 | 4 | GO:0051379 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 6.66e-08 | 6 | 165 | 4 | GO:0004936 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 1.54e-07 | 7 | 165 | 4 | GO:0005000 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC4A7 SLC5A7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC20A1 ABCC8 SLC6A5 SLC13A5 SLC41A1 | 2.17e-07 | 301 | 165 | 14 | GO:0022853 |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.59e-07 | 53 | 165 | 7 | GO:0008188 | |
| GeneOntologyMolecularFunction | peptide binding | NPY1R MCHR1 AVPR1A AVPR1B AVPR2 GPR37 FPR2 MC3R SSTR5 GRPR OPRL1 ADRB2 OXTR MRGPRX4 | 4.22e-07 | 318 | 165 | 14 | GO:0042277 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 5.48e-07 | 9 | 165 | 4 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 5.48e-07 | 9 | 165 | 4 | GO:0001640 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 5.54e-07 | 3 | 165 | 3 | GO:0001591 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 5.54e-07 | 3 | 165 | 3 | GO:1905060 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.38e-06 | 43 | 165 | 6 | GO:0140828 | |
| GeneOntologyMolecularFunction | melatonin receptor activity | 2.20e-06 | 4 | 165 | 3 | GO:0008502 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 2.20e-06 | 4 | 165 | 3 | GO:0004939 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 2.20e-06 | 4 | 165 | 3 | GO:0001642 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.53e-06 | 27 | 165 | 5 | GO:0008066 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 3.03e-06 | 49 | 165 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 4.82e-06 | 81 | 165 | 7 | GO:0015370 | |
| GeneOntologyMolecularFunction | N-formyl peptide receptor activity | 5.47e-06 | 5 | 165 | 3 | GO:0004982 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 5.47e-06 | 5 | 165 | 3 | GO:0004952 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 ABCC1 SLC22A25 SLC4A7 SLCO6A1 SLC6A9 SLC6A13 SLC17A9 SLC16A14 SLC6A5 ABCB11 SLC13A5 | 6.10e-06 | 293 | 165 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.09e-05 | 6 | 165 | 3 | GO:1905030 | |
| GeneOntologyMolecularFunction | trace-amine receptor activity | 3.01e-05 | 8 | 165 | 3 | GO:0001594 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 3.52e-05 | 23 | 165 | 4 | GO:0016493 | |
| GeneOntologyMolecularFunction | symporter activity | SLC4A7 SLC5A7 SLC6A9 SLC6A13 SLC20A1 SLC16A14 SLC6A5 SLC13A5 | 3.57e-05 | 150 | 165 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | C-C chemokine binding | 4.20e-05 | 24 | 165 | 4 | GO:0019957 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 4.49e-05 | 9 | 165 | 3 | GO:0034040 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCC3 ABCC1 SLC22A25 SLC6A9 SLC6A13 SLC16A14 SLC6A5 ABCB11 SLC13A5 | 5.77e-05 | 207 | 165 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 5.83e-05 | 26 | 165 | 4 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 5.83e-05 | 26 | 165 | 4 | GO:0004950 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.97e-05 | 119 | 165 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCC3 ABCC1 SLC22A25 SLC6A9 SLC6A13 SLC16A14 SLC6A5 ABCB11 SLC13A5 | 5.99e-05 | 208 | 165 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | calcium:sodium antiporter activity | 6.37e-05 | 10 | 165 | 3 | GO:0005432 | |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 6.79e-05 | 2 | 165 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 6.80e-05 | 27 | 165 | 4 | GO:0015271 | |
| GeneOntologyMolecularFunction | immune receptor activity | 7.01e-05 | 165 | 165 | 8 | GO:0140375 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 9.03e-05 | 55 | 165 | 5 | GO:0017046 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.02e-04 | 90 | 165 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity | 1.49e-04 | 13 | 165 | 3 | GO:0015368 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.52e-04 | 138 | 165 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | chemokine binding | 1.53e-04 | 33 | 165 | 4 | GO:0019956 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.66e-04 | 140 | 165 | 7 | GO:0099094 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.89e-04 | 14 | 165 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 1.93e-04 | 35 | 165 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | glycine:sodium symporter activity | 2.03e-04 | 3 | 165 | 2 | GO:0015375 | |
| GeneOntologyMolecularFunction | alpha1-adrenergic receptor activity | 2.03e-04 | 3 | 165 | 2 | GO:0004937 | |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 2.03e-04 | 3 | 165 | 2 | GO:0004938 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.07e-04 | 193 | 165 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.34e-04 | 15 | 165 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.39e-04 | 197 | 165 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 2.87e-04 | 16 | 165 | 3 | GO:0045125 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.92e-04 | 109 | 165 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.46e-04 | 17 | 165 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 4.03e-04 | 4 | 165 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 4.03e-04 | 4 | 165 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 4.03e-04 | 4 | 165 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 4.03e-04 | 4 | 165 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 5.09e-04 | 337 | 165 | 10 | GO:0001664 | |
| GeneOntologyMolecularFunction | scavenger receptor binding | 6.68e-04 | 5 | 165 | 2 | GO:0005124 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 6.68e-04 | 5 | 165 | 2 | GO:0099530 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 7.60e-04 | 22 | 165 | 3 | GO:0016500 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 8.69e-04 | 23 | 165 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 8.69e-04 | 23 | 165 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 9.87e-04 | 24 | 165 | 3 | GO:0031690 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 ADGRE2 ECE1 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 OR6M1 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 TAS2R50 OR4K3 | 2.24e-42 | 1395 | 166 | 74 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 HTR5A HTR7 GPER1 AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 ADGRE2 SSTR5 GRM5 GRM6 GRM7 GRM8 S1PR1 S1PR3 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 RXFP2 MTNR1A HRH4 RXFP1 | 4.02e-41 | 286 | 166 | 42 | GO:0007188 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR5A GPR37 FPR2 SSTR5 GRM5 GRM6 GRM7 GRM8 S1PR1 S1PR3 ADCY7 EDNRA OPRL1 ADRA2A RXFP2 MTNR1A HRH4 | 1.36e-32 | 86 | 166 | 25 | GO:0007193 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | GPR3 DRD2 DRD3 HTR4 HTR5A HTR7 GPER1 MC2R MC3R LGR4 ADGRE2 S1PR1 S1PR3 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 RXFP2 RXFP1 | 6.28e-22 | 191 | 166 | 24 | GO:0007189 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ABCC3 ABCC1 CHRNA6 SLC22A25 DRD2 DRD3 DRD4 HTR1B SLC4A7 MCHR1 HTR7 GPER1 SLC5A7 TMEM63B GRID1 GRM6 EDNRA CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 P2RY4 MLC1 CXCR4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 TMC5 SLC41A1 PLP1 | 2.93e-20 | 1374 | 166 | 50 | GO:0006811 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCC3 ABCC1 NPY1R HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 ECE1 EDNRA SLC6A9 SLC6A13 SLC8A2 ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 ABCC8 MTNR1B | 3.81e-19 | 344 | 166 | 27 | GO:0003018 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | NPY1R DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 MC2R MC3R SSTR5 ADRB3 MTNR1A MTNR1B HRH4 | 1.04e-18 | 61 | 166 | 15 | GO:0007187 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ABCC3 ABCC1 CHRNA6 DRD2 DRD3 DRD4 SLC4A7 GPER1 TMEM63B GRID1 GRM6 EDNRA CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 MLC1 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 TMC5 SLC41A1 PLP1 | 2.96e-18 | 1115 | 166 | 43 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | MCHR1 TRHR GPER1 GPR32 AVPR1A AVPR1B FPR1 FPR2 CCRL2 S1PR3 EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A OXTR P2RY4 CXCR6 CXCR4 HRH4 ACKR2 | 7.93e-18 | 224 | 166 | 22 | GO:0007204 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | NPY1R HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 ECE1 EDNRA ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 MTNR1B | 1.43e-17 | 202 | 166 | 21 | GO:0035296 |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | NPY1R HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 ECE1 EDNRA ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 MTNR1B | 1.43e-17 | 202 | 166 | 21 | GO:0097746 |
| GeneOntologyBiologicalProcess | regulation of tube size | NPY1R HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 ECE1 EDNRA ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 MTNR1B | 1.59e-17 | 203 | 166 | 21 | GO:0035150 |
| GeneOntologyBiologicalProcess | circulatory system process | ABCC3 ABCC1 DRD2 NPY1R DRD3 HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 MC3R ECE1 EDNRA OPRL1 SLC6A9 SLC6A13 SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 CXCR4 KCNJ2 ABCC8 MTNR1B | 8.11e-17 | 733 | 166 | 34 | GO:0003013 |
| GeneOntologyBiologicalProcess | vasoconstriction | NPY1R HTR1B HTR1D HTR7 AVPR1A AVPR1B AVPR2 ECE1 EDNRA ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B OXTR KCNA5 MTNR1B | 1.16e-16 | 121 | 166 | 17 | GO:0042310 |
| GeneOntologyBiologicalProcess | export from cell | CTAGE9 ABCC1 KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 AVPR1A SCAMP1 TVP23B CTAGE6 ADGRE2 SSTR5 GRM7 GRM8 CHRNB2 KCNK18 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 CTAGE8 MTNR1A MTNR1B ABCB11 CTAGE15 MRGPRX4 CTAGE4 | 3.64e-16 | 1153 | 166 | 41 | GO:0140352 |
| GeneOntologyBiologicalProcess | secretion | CTAGE9 ABCC3 KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR4 HTR7 GPER1 AVPR1A AVPR1B SCAMP1 TMEM63B TVP23B CTAGE6 ADGRE2 SSTR5 GRM7 GRM8 EDNRA CHRNB2 SLC6A9 SLC9A4 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 CTAGE8 MTNR1A MTNR1B ABCB11 CTAGE15 MRGPRX4 CTAGE4 | 4.69e-16 | 1221 | 166 | 42 | GO:0046903 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | DRD2 DRD3 TRHR GPR32 FPR1 FPR2 MC3R RXFP3 GRM5 S1PR1 GRPR EDNRA OPRL1 ADRA1D ADRA1A ADRA2A P2RY4 | 5.98e-16 | 133 | 166 | 17 | GO:0007200 |
| GeneOntologyBiologicalProcess | metal ion transport | DRD2 DRD3 DRD4 SLC4A7 MCHR1 GPER1 SLC5A7 GRM6 EDNRA CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 CXCR4 SLC20A1 KCNJ2 ABCC8 SLC6A5 SLC13A5 SLC41A1 PLP1 | 6.53e-16 | 1000 | 166 | 38 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | DRD2 DRD3 DRD4 SLC4A7 MCHR1 GPER1 SLC5A7 TMEM63B GRM6 EDNRA CHRNB2 KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 CXCR4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 PLP1 | 2.33e-15 | 1157 | 166 | 40 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | DRD2 DRD3 DRD4 SLC4A7 GPER1 TMEM63B GRM6 EDNRA KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 PLP1 | 3.69e-15 | 942 | 166 | 36 | GO:0098655 |
| GeneOntologyBiologicalProcess | blood circulation | DRD2 NPY1R DRD3 HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 MC3R ECE1 EDNRA OPRL1 SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 CXCR4 KCNJ2 ABCC8 MTNR1B | 7.13e-15 | 648 | 166 | 30 | GO:0008015 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | DRD2 DRD3 DRD4 SLC4A7 GPER1 GRM6 EDNRA KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 PLP1 | 1.17e-14 | 922 | 166 | 35 | GO:0098662 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPER1 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 ABCC8 SLC6A5 MTNR1B HRH4 PLP1 | 1.55e-14 | 931 | 166 | 35 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPER1 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 ABCC8 SLC6A5 MTNR1B HRH4 PLP1 | 1.55e-14 | 931 | 166 | 35 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPER1 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 ABCC8 SLC6A5 MTNR1B HRH4 PLP1 | 2.00e-14 | 939 | 166 | 35 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of blood circulation | DRD2 NPY1R HTR7 AVPR1A AVPR1B AVPR2 MC3R ECE1 EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 OXTR KCNA5 KCNJ2 MTNR1B | 2.15e-14 | 326 | 166 | 22 | GO:1903522 |
| GeneOntologyBiologicalProcess | synaptic signaling | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPER1 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 ABCC8 SLC6A5 MTNR1B HRH4 PLP1 | 6.26e-14 | 976 | 166 | 35 | GO:0099536 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | DRD2 DRD3 DRD4 SLC4A7 GPER1 GRM6 EDNRA KCNK18 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 SLC30A5 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 SLC20A1 KCNJ2 ABCC8 SLC6A5 OTOP1 SLC13A5 SLC41A1 PLP1 | 2.08e-13 | 1017 | 166 | 35 | GO:0098660 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 2.08e-13 | 25 | 166 | 9 | GO:0071880 | |
| GeneOntologyBiologicalProcess | secretion by cell | CTAGE9 KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 AVPR1A SCAMP1 TVP23B CTAGE6 ADGRE2 SSTR5 GRM7 GRM8 CHRNB2 SLC6A9 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 CTAGE8 MTNR1A MTNR1B CTAGE15 MRGPRX4 CTAGE4 | 7.65e-13 | 1064 | 166 | 35 | GO:0032940 |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | NPY1R HTR7 AVPR1A AVPR1B AVPR2 ECE1 ADRA1D ADRA1A ADRA2A ADRA2B OXTR KCNA5 MTNR1B | 1.10e-12 | 98 | 166 | 13 | GO:0019229 |
| GeneOntologyBiologicalProcess | regulation of system process | KDM5B DRD2 NPY1R DRD4 HTR7 GPER1 AVPR1A AVPR1B AVPR2 MC3R ECE1 EDNRA CHRNB2 SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 ADRB2 OXTR KCNA5 KCNC4 KCNJ2 ABCC8 MTNR1B | 1.14e-12 | 734 | 166 | 29 | GO:0044057 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | DRD3 AVPR1A AVPR1B AVPR2 ECE1 ADRA1D ADRA1A ADRB1 ADRB2 ADRB3 OXTR | 1.94e-12 | 61 | 166 | 11 | GO:0003044 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CHRNA6 DRD2 DRD4 GPER1 GRID1 GRM5 CHRNB2 KCNK18 SLC8A2 SLC8A1 SLC8A3 ADRA1A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 MTNR1B | 3.42e-12 | 559 | 166 | 25 | GO:0042391 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | DRD2 NPY1R HTR1D HTR7 GPER1 EDNRA CHRNB2 SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 OXTR | 3.68e-12 | 133 | 166 | 14 | GO:0006939 |
| GeneOntologyBiologicalProcess | behavior | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D SLC4A7 MCHR1 HTR7 AVPR1A GPR37 MC3R GRID1 GRM5 GRM6 GRM7 GRPR CHRNB2 OPRL1 SLC8A2 SLC8A3 ADRB1 KCNA2 ADRB2 ADRB3 OXTR ABCC8 MTNR1A MTNR1B MRGPRX4 VPS13B | 4.66e-12 | 891 | 166 | 31 | GO:0007610 |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | CHRNA6 DRD2 DRD4 HTR1B HTR7 GRM7 GRM8 CHRNB2 ADRA1A ADRA2A ADRB2 | 5.72e-12 | 67 | 166 | 11 | GO:0099171 |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 6.57e-12 | 23 | 166 | 8 | GO:0098664 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 6.72e-12 | 35 | 166 | 9 | GO:0071875 | |
| GeneOntologyBiologicalProcess | action potential | GPER1 CHRNB2 SLC8A2 SLC8A1 ADRA1A KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 MTNR1B | 7.59e-12 | 201 | 166 | 16 | GO:0001508 |
| GeneOntologyBiologicalProcess | regulation of blood pressure | DRD2 NPY1R DRD3 AVPR1A AVPR1B AVPR2 MC3R ECE1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2B ADRB1 ADRB2 ADRB3 OXTR | 8.70e-12 | 237 | 166 | 17 | GO:0008217 |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 3.88e-11 | 59 | 166 | 10 | GO:0045761 | |
| GeneOntologyBiologicalProcess | regulation of secretion | KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B ADGRE2 SSTR5 GRM7 GRM8 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 MTNR1A MTNR1B ABCB11 | 5.22e-11 | 801 | 166 | 28 | GO:0051046 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 | 1.32e-10 | 663 | 166 | 25 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 SLC6A9 SLC8A2 SLC8A3 ADRA1A ADRA2A ADRB1 ADRB2 OXTR KCNC4 P2RY4 | 1.36e-10 | 664 | 166 | 25 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.96e-10 | 69 | 166 | 10 | GO:0031279 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 2.26e-10 | 34 | 166 | 8 | GO:0007190 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 AVPR1A ADGRE2 SSTR5 GRM7 GRM8 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 MTNR1A MTNR1B | 2.49e-10 | 740 | 166 | 26 | GO:1903530 |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 3.49e-10 | 73 | 166 | 10 | GO:0051339 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | DRD2 DRD3 AVPR1A AVPR1B AVPR2 ECE1 ADRA1D ADRA1A ADRB1 ADRB2 ADRB3 OXTR | 3.62e-10 | 124 | 166 | 12 | GO:0003073 |
| GeneOntologyBiologicalProcess | regulation of amine transport | CHRNA6 DRD2 DRD3 DRD4 HTR1B AVPR1A GRM7 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR | 3.97e-10 | 125 | 166 | 12 | GO:0051952 |
| GeneOntologyBiologicalProcess | regulation of behavior | DRD2 DRD3 HTR1B HTR1D MCHR1 MC3R GRPR CHRNB2 OPRL1 ADRB1 KCNA2 MTNR1B | 5.24e-10 | 128 | 166 | 12 | GO:0050795 |
| GeneOntologyBiologicalProcess | signal release | KDM5B CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR7 GPER1 SSTR5 GRM8 CHRNB2 SLC6A9 ADRA2A ADRA2B KCNA2 OXTR KCNA5 KCNC4 P2RY4 ABCC8 MTNR1A MTNR1B | 5.36e-10 | 653 | 166 | 24 | GO:0023061 |
| GeneOntologyBiologicalProcess | muscle contraction | DRD2 NPY1R HTR1D HTR7 GPER1 EDNRA CHRNB2 SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 ADRB2 OXTR KCNA5 CXCR4 KCNJ2 | 6.04e-10 | 400 | 166 | 19 | GO:0006936 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 6.59e-10 | 7 | 166 | 5 | GO:0007198 | |
| GeneOntologyBiologicalProcess | potassium ion transport | DRD2 DRD3 KCNK18 SLC9A4 ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 6.92e-10 | 272 | 166 | 16 | GO:0006813 |
| GeneOntologyBiologicalProcess | sodium ion transport | DRD2 DRD4 SLC4A7 SLC5A7 EDNRA SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRB2 SLC20A1 SLC6A5 SLC13A5 SLC41A1 | 8.12e-10 | 275 | 166 | 16 | GO:0006814 |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 9.18e-10 | 40 | 166 | 8 | GO:0045762 | |
| GeneOntologyBiologicalProcess | amine transport | CHRNA6 DRD2 DRD3 DRD4 HTR1B AVPR1A GRM7 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR | 1.15e-09 | 137 | 166 | 12 | GO:0015837 |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by norepinephrine-epinephrine | 1.75e-09 | 8 | 166 | 5 | GO:0001993 | |
| GeneOntologyBiologicalProcess | monoamine transport | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR7 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR | 2.49e-09 | 116 | 166 | 11 | GO:0015844 |
| GeneOntologyBiologicalProcess | neurotransmitter transport | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D GPER1 SLC5A7 GRM8 SLC6A9 SLC6A13 KCNC4 P2RY4 ABCC8 SLC6A5 | 2.99e-09 | 259 | 166 | 15 | GO:0006836 |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 3.27e-09 | 67 | 166 | 9 | GO:0050433 | |
| GeneOntologyBiologicalProcess | muscle system process | DRD2 NPY1R HTR1D HTR7 GPER1 ECE1 EDNRA CHRNB2 SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 ADRB2 OXTR KCNA5 CXCR4 KCNJ2 ABCC8 | 3.30e-09 | 547 | 166 | 21 | GO:0003012 |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 4.26e-09 | 48 | 166 | 8 | GO:0031281 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CTAGE9 GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B SLC4A7 GPER1 AVPR1A MC3R TMEM63B SSTR5 GRM5 EDNRA SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRA2A KCNA1 ADRB1 SLC30A5 KCNA5 P2RY4 KCNJ2 ABCC8 CTAGE8 MTNR1B ABCB11 SLC41A1 FITM2 | 4.68e-09 | 1249 | 166 | 32 | GO:0048878 |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 5.06e-09 | 49 | 166 | 8 | GO:0051349 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 5.40e-09 | 96 | 166 | 10 | GO:0051937 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | ABCC1 GRM6 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 ADRB1 ADRB2 SLC30A5 KCNJ2 ABCC8 SLC6A5 | 5.45e-09 | 230 | 166 | 14 | GO:0098739 |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC3 ABCC1 SLC22A25 DRD2 DRD3 DRD4 HTR1B SLC4A7 AVPR1A AVPR1B GRM7 SLCO6A1 SLC6A9 SLC6A13 SLC17A9 ABCC8 SLC16A14 SLC6A5 ABCB11 SLC13A5 | 6.63e-09 | 515 | 166 | 20 | GO:0015711 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 9.83e-09 | 132 | 166 | 11 | GO:0035249 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 1.45e-08 | 79 | 166 | 9 | GO:0050432 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by vasopressin | 2.01e-08 | 5 | 166 | 4 | GO:0001992 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 2.32e-08 | 59 | 166 | 8 | GO:0045777 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | CHRNA6 DRD2 DRD4 GRID1 GRM5 CHRNB2 SLC8A2 SLC8A3 KCNA1 ADRB1 KCNA2 ADRB2 | 2.56e-08 | 180 | 166 | 12 | GO:0060078 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | NPY1R HTR1B HTR1D HTR7 GPER1 AVPR1A AVPR1B AVPR2 ECE1 EDNRA ADRA1D SLC8A1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR KCNA5 MTNR1B | 2.75e-08 | 618 | 166 | 21 | GO:0090066 |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 3.87e-08 | 25 | 166 | 6 | GO:0051481 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B SLC4A7 GPER1 AVPR1A MC3R GRM5 EDNRA SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 SLC30A5 KCNA5 P2RY4 KCNJ2 SLC41A1 | 5.65e-08 | 705 | 166 | 22 | GO:0055080 |
| GeneOntologyBiologicalProcess | learning or memory | DRD2 DRD3 DRD4 HTR7 GRM5 GRM7 GRPR CHRNB2 OPRL1 SLC8A2 SLC8A3 ADRB1 ADRB2 OXTR ABCC8 VPS13B | 6.10e-08 | 373 | 166 | 16 | GO:0007611 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B SLC4A7 GPER1 AVPR1A MC3R GRM5 EDNRA SLC8A2 SLC9A4 SLC8A1 SLC8A3 KCNA1 SLC30A5 KCNA5 P2RY4 KCNJ2 SLC41A1 | 7.59e-08 | 717 | 166 | 22 | GO:0050801 |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | HTR7 GPER1 SLC8A1 SLC8A3 ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 ADRB2 OXTR KCNJ2 | 9.14e-08 | 202 | 166 | 12 | GO:0006937 |
| GeneOntologyBiologicalProcess | negative regulation of blood pressure | 9.18e-08 | 70 | 166 | 8 | GO:0045776 | |
| GeneOntologyBiologicalProcess | circadian behavior | 1.03e-07 | 71 | 166 | 8 | GO:0048512 | |
| GeneOntologyBiologicalProcess | circadian rhythm | KDM5B DRD2 DRD3 DRD4 HTR7 MC3R LGR4 CHRNB2 OPRL1 ADRB1 KCNA2 MTNR1A MTNR1B | 1.13e-07 | 248 | 166 | 13 | GO:0007623 |
| GeneOntologyBiologicalProcess | regulation of heart contraction | DRD2 AVPR1A MC3R EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRB1 ADRB2 KCNA5 KCNJ2 | 1.19e-07 | 249 | 166 | 13 | GO:0008016 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | DRD4 SLC4A7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC20A1 SLC6A5 SLC13A5 SLC41A1 | 1.26e-07 | 208 | 166 | 12 | GO:0035725 |
| GeneOntologyBiologicalProcess | sensory perception | DRD2 NPY1R SLC4A7 OR9A4 LHFPL4 HTR7 OR4K13 OR6K2 TMEM63B TAAR3P OPN1SW GRM6 GRM7 GRM8 OR6M1 CHRNB2 OPRL1 ADRA2A TAS2R14 KCNA1 KCNA2 CXCR4 OR56A5 OR56A4 OR56A1 TAS2R50 OR4K3 | 1.27e-07 | 1072 | 166 | 27 | GO:0007600 |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure by epinephrine-norepinephrine | 1.39e-07 | 7 | 166 | 4 | GO:0003321 | |
| GeneOntologyBiologicalProcess | heart contraction | DRD2 AVPR1A MC3R EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRB1 ADRB2 KCNA5 CXCR4 KCNJ2 | 1.40e-07 | 298 | 166 | 14 | GO:0060047 |
| GeneOntologyBiologicalProcess | social behavior | 1.43e-07 | 74 | 166 | 8 | GO:0035176 | |
| GeneOntologyBiologicalProcess | rhythmic behavior | 1.43e-07 | 74 | 166 | 8 | GO:0007622 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle, sleep | 1.55e-07 | 31 | 166 | 6 | GO:0045187 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | DRD2 NPY1R DRD3 DRD4 HTR1B HTR7 GRM7 ADRA2A ADRA2B ABCC8 MTNR1A MTNR1B | 1.71e-07 | 214 | 166 | 12 | GO:1903531 |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 1.76e-07 | 76 | 166 | 8 | GO:0051703 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | DRD2 DRD3 DRD4 HTR1B MCHR1 HTR7 GPER1 GRM6 EDNRA SLC6A9 SLC8A1 ADRA2A ADRB1 ADRB2 KCNA5 CXCR4 KCNJ2 ABCC8 PLP1 | 2.16e-07 | 577 | 166 | 19 | GO:0043269 |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 2.17e-07 | 141 | 166 | 10 | GO:0051588 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | ABCC3 KDM5B CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR7 ABCA13 CHRNB2 ADRA2A ADRA2B KCNA2 OXTR ABCB11 | 2.18e-07 | 358 | 166 | 15 | GO:0015850 |
| GeneOntologyBiologicalProcess | heart process | DRD2 AVPR1A MC3R EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRB1 ADRB2 KCNA5 CXCR4 KCNJ2 | 2.19e-07 | 309 | 166 | 14 | GO:0003015 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | ABCC3 ABCC1 DRD2 DRD3 DRD4 HTR1B AVPR1A AVPR1B GRM7 SLC6A9 SLC6A13 ABCC8 SLC16A14 SLC6A5 ABCB11 SLC13A5 | 2.21e-07 | 410 | 166 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, sleep | 2.30e-07 | 33 | 166 | 6 | GO:0050802 | |
| GeneOntologyCellularComponent | synaptic membrane | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B LHFPL4 HTR5A HTR7 GPER1 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNC4 P2RY4 KCNJ2 SLC6A5 | 7.13e-18 | 583 | 169 | 32 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | CHRNA6 DRD2 DRD3 DRD4 LHFPL4 HTR5A HTR7 GPER1 GRID1 GRM5 GRM6 GRM7 CHRNB2 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNC4 KCNJ2 | 2.81e-15 | 405 | 169 | 25 | GO:0045211 |
| GeneOntologyCellularComponent | presynaptic membrane | CHRNA6 DRD2 NPY1R DRD4 HTR1B HTR7 GPER1 SLC5A7 GRM7 GRM8 CHRNB2 SLC6A9 ADRA1A ADRA2A KCNA1 KCNA2 KCNA3 KCNC4 P2RY4 SLC6A5 | 1.11e-13 | 277 | 169 | 20 | GO:0042734 |
| GeneOntologyCellularComponent | neuron projection terminus | DRD2 DRD4 HTR1B HTR7 GPER1 OPN1SW GRM7 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 KCNA3 KCNA6 KCNC4 MACO1 | 7.20e-12 | 233 | 169 | 17 | GO:0044306 |
| GeneOntologyCellularComponent | axon terminus | DRD2 DRD4 HTR1B HTR7 GPER1 OPN1SW GRM7 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 KCNA3 KCNA6 KCNC4 | 1.60e-11 | 210 | 169 | 16 | GO:0043679 |
| GeneOntologyCellularComponent | presynapse | CHRNA6 DRD2 NPY1R DRD4 HTR1B HTR7 GPER1 SCAMP1 SLC5A7 OPN1SW GRM7 GRM8 S1PR1 S1PR3 CHRNB2 SLC6A9 SLC6A13 SLC8A2 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 KCNA2 KCNA3 KCNA6 KCNC4 P2RY4 ABCC8 SLC6A5 | 2.45e-11 | 886 | 169 | 30 | GO:0098793 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ABCC3 ABCC1 SLC22A25 SLC4A7 SLCO6A1 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 ADRA2A P2RY4 MLC1 PROM2 ABCB11 SLC13A5 SLC41A1 | 1.02e-09 | 320 | 169 | 17 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | ABCC3 ABCC1 SLC22A25 SLC4A7 SLCO6A1 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 ADRA2A P2RY4 MLC1 PROM2 ABCB11 SLC13A5 SLC41A1 | 4.69e-09 | 354 | 169 | 17 | GO:0009925 |
| GeneOntologyCellularComponent | potassium channel complex | KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 1.24e-08 | 104 | 169 | 10 | GO:0034705 |
| GeneOntologyCellularComponent | basal part of cell | ABCC3 ABCC1 SLC22A25 SLC4A7 SLCO6A1 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 ADRA2A P2RY4 MLC1 PROM2 ABCB11 SLC13A5 SLC41A1 | 1.24e-08 | 378 | 169 | 17 | GO:0045178 |
| GeneOntologyCellularComponent | postsynapse | CHRNA6 DRD2 DRD3 DRD4 LHFPL4 HTR4 GPR50 HTR5A HTR7 GPER1 UBE3B GRID1 GRM5 GRM6 GRM7 CHRNB2 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA1A ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNC4 KCNJ2 | 1.25e-08 | 1018 | 169 | 28 | GO:0098794 |
| GeneOntologyCellularComponent | dopaminergic synapse | 1.71e-08 | 22 | 169 | 6 | GO:0098691 | |
| GeneOntologyCellularComponent | dendrite | DRD2 DRD4 HTR1B HTR1D HTR1F LHFPL4 HTR4 HTR5A HTR7 GPER1 GPR37 ELOVL5 SLC5A7 GRM5 GRM6 GRM7 SLC8A2 SLC8A1 SLC8A3 KCNA1 KCNA2 ADRB2 KCNC4 KCNJ2 HRH4 | 2.74e-08 | 858 | 169 | 25 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DRD2 DRD4 HTR1B HTR1D HTR1F LHFPL4 HTR4 HTR5A HTR7 GPER1 GPR37 ELOVL5 SLC5A7 GRM5 GRM6 GRM7 SLC8A2 SLC8A1 SLC8A3 KCNA1 KCNA2 ADRB2 KCNC4 KCNJ2 HRH4 | 2.87e-08 | 860 | 169 | 25 | GO:0097447 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 5.29e-08 | 91 | 169 | 9 | GO:0008076 | |
| GeneOntologyCellularComponent | distal axon | DRD2 DRD4 HTR1B HTR7 GPER1 OPN1SW GRM7 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 KCNA3 KCNA6 KCNC4 CXCR4 | 9.54e-08 | 435 | 169 | 17 | GO:0150034 |
| GeneOntologyCellularComponent | somatodendritic compartment | DRD2 DRD4 HTR1B HTR1D HTR1F LHFPL4 HTR4 HTR5A HTR7 GPER1 GPR37 ELOVL5 SLC5A7 GRM5 GRM6 GRM7 GRM8 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 ADRB2 KCNC4 KCNJ2 MTNR1A HRH4 MRGPRX4 | 1.79e-07 | 1228 | 169 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | cation channel complex | SLCO6A1 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 CATSPERG | 4.94e-07 | 235 | 169 | 12 | GO:0034703 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CHRNA6 SLCO6A1 CHRNB2 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 CATSPERG | 2.55e-06 | 378 | 169 | 14 | GO:0034702 |
| GeneOntologyCellularComponent | axon | DRD2 NPY1R DRD4 HTR1B HTR7 GPER1 SLC5A7 OPN1SW GRM7 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNA6 KCNC4 CXCR4 MACO1 MRGPRX4 | 3.18e-06 | 891 | 169 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | dense core granule | 5.94e-06 | 56 | 169 | 6 | GO:0031045 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 7.73e-06 | 164 | 169 | 9 | GO:0098982 | |
| GeneOntologyCellularComponent | calyx of Held | 1.00e-05 | 36 | 169 | 5 | GO:0044305 | |
| GeneOntologyCellularComponent | apical plasma membrane | ABCC1 SLC4A7 SLC5A7 SLC6A9 PROM1 SLC9A4 KCNA1 ADRB2 SLC30A5 OXTR KCNA5 P2RY4 MLC1 PROM2 ABCB11 | 1.03e-05 | 487 | 169 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | glutamatergic synapse | DRD2 NPY1R DRD3 DRD4 HTR1D HTR4 UBE3B GRID1 GRM5 GRM7 GRM8 ADRA1A ADRA2A KCNA1 KCNA2 ADRB2 KCNA3 KCNC4 P2RY4 KCNJ2 | 1.05e-05 | 817 | 169 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | DRD2 DRD4 HTR5A HTR7 GPER1 ELOVL5 SLC5A7 GRM7 GRM8 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 ADRB2 KCNC4 KCNJ2 MTNR1A MRGPRX4 | 1.44e-05 | 835 | 169 | 20 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | DRD2 DRD4 HTR5A HTR7 GPER1 ELOVL5 SLC5A7 OPN1SW GRM7 GRM8 SLC8A2 SLC8A1 SLC8A3 ADRA2A KCNA1 KCNA2 ADRB2 KCNC4 KCNJ2 MTNR1A MRGPRX4 | 2.05e-05 | 929 | 169 | 21 | GO:0044297 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.17e-05 | 42 | 169 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | apical part of cell | ABCC1 DRD3 SLC4A7 SLC5A7 SLC6A9 PROM1 SLC9A4 KCNA1 ADRB2 SLC30A5 OXTR KCNA5 P2RY4 MLC1 PROM2 ABCB11 | 2.60e-05 | 592 | 169 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | prominosome | 6.50e-05 | 2 | 169 | 2 | GO:0071914 | |
| GeneOntologyCellularComponent | endosome | HTR4 GPER1 AVPR1A AVPR1B AVPR2 SCAMP1 SLC5A7 TMEM63B SCAMP2 ECE1 S1PR1 SLC6A9 YIPF2 ADRB1 ADRB2 TM9SF2 YIPF1 MLC1 CXCR4 SLC6A5 ABCB11 ACKR2 VPS13B | 6.84e-05 | 1167 | 169 | 23 | GO:0005768 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CHRNA6 SLCO6A1 CHRNB2 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 CATSPERG | 9.37e-05 | 523 | 169 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CHRNA6 SLCO6A1 CHRNB2 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 CATSPERG | 1.58e-04 | 550 | 169 | 14 | GO:1990351 |
| GeneOntologyCellularComponent | dendritic spine | 1.61e-04 | 242 | 169 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | sarcolemma | 1.61e-04 | 190 | 169 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | neuron spine | 1.88e-04 | 247 | 169 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 1.98e-04 | 36 | 169 | 4 | GO:0098992 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CHRNA6 DRD2 SLCO6A1 IFNLR1 CHRNB2 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 CATSPERG PLP1 | 2.19e-04 | 785 | 169 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | postsynaptic specialization | DRD3 LHFPL4 GPR50 HTR5A GPER1 GRID1 GRM5 CHRNB2 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA2A | 2.36e-04 | 503 | 169 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 3.01e-04 | 112 | 169 | 6 | GO:0032588 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CTAGE9 TEX261 MBOAT1 GPER1 GPR37 ELOVL5 FAXDC2 BFAR CTAGE6 PIGU GRM6 SLC8A3 FADS1 KCNA2 SLC30A5 MACO1 CTAGE8 TMX4 CTAGE15 LTC4S CTAGE4 FITM2 ALG6 | 3.08e-04 | 1293 | 169 | 23 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CTAGE9 TEX261 MBOAT1 GPER1 GPR37 ELOVL5 FAXDC2 BFAR CTAGE6 PIGU GRM6 SLC8A3 FADS1 KCNA2 SLC30A5 MACO1 CTAGE8 TMX4 CTAGE15 LTC4S CTAGE4 FITM2 ALG6 | 3.28e-04 | 1299 | 169 | 23 | GO:0098827 |
| GeneOntologyCellularComponent | neuronal cell body membrane | 3.98e-04 | 43 | 169 | 4 | GO:0032809 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CTAGE9 TEX261 MBOAT1 GPER1 GPR37 ELOVL5 FAXDC2 BFAR CTAGE6 PIGU GRM6 SLC8A3 FADS1 KCNA2 SLC30A5 MACO1 CTAGE8 TMX4 CTAGE15 LTC4S CTAGE4 FITM2 ALG6 | 4.43e-04 | 1327 | 169 | 23 | GO:0042175 |
| GeneOntologyCellularComponent | secretory vesicle | DRD2 NPY1R HTR1D HTR7 ABCA13 SCAMP1 FPR1 FPR2 SLC5A7 TMEM63B RCBTB2 ECE1 SLC6A9 SLC9A4 ADRB1 ADRB2 SLC30A5 KCNC4 SLC17A9 ABCC8 SLC6A5 VPS13B | 4.64e-04 | 1246 | 169 | 22 | GO:0099503 |
| GeneOntologyCellularComponent | cell body membrane | 5.61e-04 | 47 | 169 | 4 | GO:0044298 | |
| GeneOntologyCellularComponent | intracellular canaliculus | 6.39e-04 | 5 | 169 | 2 | GO:0046691 | |
| GeneOntologyCellularComponent | membrane raft | SLC5A7 S1PR1 CHRNB2 NPHS2 ADRA1A ADRB2 KCNA3 KCNA5 MLC1 PROM2 | 7.51e-04 | 362 | 169 | 10 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | SLC5A7 S1PR1 CHRNB2 NPHS2 ADRA1A ADRB2 KCNA3 KCNA5 MLC1 PROM2 | 7.83e-04 | 364 | 169 | 10 | GO:0098857 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | DRD2 GPER1 ABCA13 AVPR2 SCAMP1 FPR1 FPR2 SLC5A7 TMEM63B SCAMP2 ECE1 SLC6A9 YIPF2 SLC9A4 ADRB2 SLC30A5 TM9SF2 YIPF1 SLC17A9 ABCC8 ABCB11 VPS13B | 8.75e-04 | 1307 | 169 | 22 | GO:0030659 |
| GeneOntologyCellularComponent | trans-Golgi network | 8.88e-04 | 306 | 169 | 9 | GO:0005802 | |
| GeneOntologyCellularComponent | receptor complex | CHRNA6 DRD2 HTR1B GPR37 GPR63 GRM7 IFNLR1 CHRNB2 ADRA2A ADRB2 ADRB3 MTNR1A PLP1 | 9.12e-04 | 581 | 169 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | vesicle membrane | DRD2 GPER1 ABCA13 AVPR2 SCAMP1 FPR1 FPR2 SLC5A7 TMEM63B SCAMP2 ECE1 SLC6A9 YIPF2 SLC9A4 ADRB2 SLC30A5 TM9SF2 YIPF1 SLC17A9 ABCC8 ABCB11 VPS13B | 1.05e-03 | 1325 | 169 | 22 | GO:0012506 |
| GeneOntologyCellularComponent | transport vesicle | DRD2 NPY1R HTR7 SCAMP1 SLC5A7 SLC6A9 YIPF2 SLC30A5 YIPF1 KCNC4 SLC17A9 ABCC8 | 1.08e-03 | 519 | 169 | 12 | GO:0030133 |
| GeneOntologyCellularComponent | plasma membrane raft | 1.26e-03 | 147 | 169 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | secretory granule | DRD2 NPY1R HTR1D ABCA13 SCAMP1 FPR1 FPR2 TMEM63B RCBTB2 ECE1 SLC6A9 SLC9A4 ADRB1 ADRB2 SLC30A5 SLC17A9 SLC6A5 VPS13B | 1.47e-03 | 1014 | 169 | 18 | GO:0030141 |
| GeneOntologyCellularComponent | secretory granule membrane | ABCA13 SCAMP1 FPR1 FPR2 TMEM63B SLC9A4 SLC30A5 SLC17A9 VPS13B | 1.47e-03 | 329 | 169 | 9 | GO:0030667 |
| GeneOntologyCellularComponent | cell surface | TRHR GPR37 CCRL2 ADGRE2 ECE1 GRM7 S1PR1 CHRNB2 PROM1 ADRA2B KCNA1 ICOS KCNA5 KCNC4 CXCR6 PROM2 CXCR4 ABCB11 ACKR2 | 1.67e-03 | 1111 | 169 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | asymmetric synapse | DRD3 GPR50 GPER1 GRID1 GRM5 GRM7 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA2A | 1.78e-03 | 477 | 169 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | recycling endosome | 2.24e-03 | 222 | 169 | 7 | GO:0055037 | |
| GeneOntologyCellularComponent | perikaryon | 2.29e-03 | 223 | 169 | 7 | GO:0043204 | |
| GeneOntologyCellularComponent | dendritic shaft | 3.06e-03 | 74 | 169 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.13e-03 | 300 | 169 | 8 | GO:0008021 | |
| GeneOntologyCellularComponent | Golgi trans cisterna | 3.41e-03 | 11 | 169 | 2 | GO:0000138 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | DRD3 GPR50 GPER1 GRID1 GRM5 GRM7 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA2A | 3.60e-03 | 523 | 169 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.69e-03 | 78 | 169 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | postsynaptic density | DRD3 GPR50 GPER1 GRID1 GRM5 SLC6A9 SLC8A2 SLC8A1 SLC8A3 ADRA2A | 3.77e-03 | 451 | 169 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | T-tubule | 3.87e-03 | 79 | 169 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 4.07e-03 | 12 | 169 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | exocytic vesicle | 4.60e-03 | 320 | 169 | 8 | GO:0070382 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.82e-03 | 141 | 169 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | early endosome | GPER1 SLC5A7 TMEM63B ECE1 ADRB1 ADRB2 MLC1 CXCR4 ACKR2 VPS13B | 5.88e-03 | 481 | 169 | 10 | GO:0005769 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.95e-03 | 201 | 169 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | CatSper complex | 6.37e-03 | 15 | 169 | 2 | GO:0036128 | |
| GeneOntologyCellularComponent | ciliary membrane | 8.26e-03 | 98 | 169 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | coated vesicle | 9.12e-03 | 360 | 169 | 8 | GO:0030135 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 9.13e-03 | 18 | 169 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 9.96e-03 | 293 | 169 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | endosome membrane | SCAMP1 SLC5A7 TMEM63B SCAMP2 ECE1 YIPF2 ADRB2 TM9SF2 YIPF1 ABCB11 VPS13B | 9.98e-03 | 602 | 169 | 11 | GO:0010008 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.01e-02 | 443 | 169 | 9 | GO:0098791 | |
| GeneOntologyCellularComponent | zymogen granule membrane | 1.12e-02 | 20 | 169 | 2 | GO:0042589 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.12e-02 | 20 | 169 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | caveola | 1.26e-02 | 111 | 169 | 4 | GO:0005901 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 1.28e-02 | 237 | 169 | 6 | GO:0030136 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 1.30e-02 | 112 | 169 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.47e-02 | 23 | 169 | 2 | GO:0005797 | |
| MousePheno | abnormal behavioral response to xenobiotic | DRD2 NPY1R DRD3 DRD4 MCHR1 HTR4 HTR7 AVPR1B MC2R GRM5 GRM7 CHRNB2 OPRL1 ADRA1D KCNA1 KCNA2 | 7.96e-08 | 309 | 140 | 16 | MP:0009745 |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 2.85e-07 | 118 | 140 | 10 | MP:0012349 | |
| MousePheno | impaired behavioral response to addictive substance | 2.87e-07 | 45 | 140 | 7 | MP:0009750 | |
| MousePheno | impaired behavioral response to xenobiotic | 1.74e-06 | 83 | 140 | 8 | MP:0009747 | |
| MousePheno | abnormal synaptic transmission | DRD2 HTR1F LHFPL4 MBOAT1 AVPR1A ABCA13 GPR37 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 EDNRA CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC9A4 ADRA1D SLC8A3 ADRA2A KCNA1 KCNA2 KCNA5 SLC6A5 MTNR1B FITM2 | 2.11e-06 | 1070 | 140 | 28 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | DRD2 HTR1F LHFPL4 MBOAT1 AVPR1A ABCA13 GPR37 SLC5A7 GRID1 GRM5 GRM6 GRM7 GRM8 EDNRA CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC9A4 ADRA1D SLC8A3 ADRA2A KCNA1 KCNA2 KCNA5 SLC6A5 MTNR1B FITM2 | 2.36e-06 | 1076 | 140 | 28 | MP:0021009 |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 2.59e-06 | 117 | 140 | 9 | MP:0002906 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | ABCC3 GPR3 KDM5B DRD2 NPY1R DRD3 HTR1B HTR1F MBOAT1 HTR7 ELOVL5 SLC5A7 TMEM63B SCAMP2 SSTR5 GRM5 GRM6 GRM7 EDNRA CHRNB2 OPRL1 SLC6A9 SLC9A4 ADRA1D ADRA2A KCNA1 KCNA2 OXTR KCNA6 SLC6A5 OTOP1 ALG6 PLP1 VPS13B | 2.87e-06 | 1486 | 140 | 34 | MP:0002067 |
| MousePheno | abnormal seizure response to inducing agent | DRD2 HTR4 HTR7 AVPR1B MC2R GRM5 GRM7 CHRNB2 KCNA1 KCNA2 PLP1 | 5.56e-06 | 201 | 140 | 11 | MP:0009357 |
| MousePheno | abnormal behavioral response to addictive substance | 8.22e-06 | 102 | 140 | 8 | MP:0009748 | |
| MousePheno | abnormal vasoconstriction | 1.00e-05 | 50 | 140 | 6 | MP:0000250 | |
| MousePheno | abnormal percent body fat/body weight | 1.42e-05 | 144 | 140 | 9 | MP:0005457 | |
| MousePheno | abnormal pain threshold | ABCC3 GPR3 HTR1F HTR7 SLC5A7 GRM5 GRM7 CHRNB2 OPRL1 SLC6A9 KCNA1 KCNA6 | 1.54e-05 | 267 | 140 | 12 | MP:0001970 |
| MousePheno | abnormal seizure response to pharmacological agent | 1.67e-05 | 147 | 140 | 9 | MP:0000950 | |
| MousePheno | increased percent body fat/body weight | 2.91e-05 | 60 | 140 | 6 | MP:0005458 | |
| MousePheno | decreased chemically-elicited antinociception | 3.32e-05 | 19 | 140 | 4 | MP:0001982 | |
| MousePheno | abnormal CNS synaptic transmission | DRD2 HTR1F LHFPL4 MBOAT1 AVPR1A ABCA13 GPR37 GRID1 GRM5 GRM7 GRM8 EDNRA CHRNB2 OPRL1 SLC6A9 SLC8A2 SLC9A4 ADRA1D ADRA2A KCNA1 KCNA2 SLC6A5 MTNR1B FITM2 | 4.09e-05 | 985 | 140 | 24 | MP:0002206 |
| MousePheno | abnormal xenobiotic induced morbidity/mortality | 5.52e-05 | 171 | 140 | 9 | MP:0009765 | |
| MousePheno | seizures | DRD2 HTR4 HTR7 AVPR1B MC2R GRM5 GRM7 CHRNB2 ADRA2A KCNA1 KCNA2 SLC6A5 PLP1 | 6.64e-05 | 360 | 140 | 13 | MP:0002064 |
| MousePheno | abnormal vascular smooth muscle physiology | 8.14e-05 | 140 | 140 | 8 | MP:0005595 | |
| MousePheno | abnormal behavioral response to alcohol | 8.76e-05 | 24 | 140 | 4 | MP:0020157 | |
| MousePheno | abnormal learning/memory/conditioning | DRD2 NPY1R DRD3 DRD4 HTR1B AADACL4 MCHR1 HTR4 HTR5A AVPR1A FPR2 ELOVL5 GRM5 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 ADRA1D FADS1 OXTR KCNA6 MTNR1B ALG6 VPS13B SLC44A3 | 8.77e-05 | 1239 | 140 | 27 | MP:0002063 |
| MousePheno | abnormal cognition | DRD2 NPY1R DRD3 DRD4 HTR1B AADACL4 MCHR1 HTR4 HTR5A AVPR1A FPR2 ELOVL5 GRM5 GRM7 GRM8 CHRNB2 OPRL1 SLC6A9 SLC8A2 ADRA1D FADS1 OXTR KCNA6 MTNR1B ALG6 VPS13B SLC44A3 | 9.65e-05 | 1246 | 140 | 27 | MP:0014114 |
| MousePheno | abnormal heart rate | DRD2 NPY1R SLC4A7 MCHR1 AVPR1A MC2R SLC8A1 ADRA1A ADRA2A KCNA1 ADRB2 SLC30A5 KCNA7 RXFP2 | 1.50e-04 | 445 | 140 | 14 | MP:0001629 |
| MousePheno | abnormal chemically-elicited antinociception | 1.88e-04 | 29 | 140 | 4 | MP:0001980 | |
| MousePheno | double aortic arch | 2.02e-04 | 12 | 140 | 3 | MP:0004159 | |
| MousePheno | abnormal circulating corticosterone level | 2.50e-04 | 88 | 140 | 6 | MP:0005345 | |
| MousePheno | absent malleus | 2.97e-04 | 3 | 140 | 2 | MP:0004319 | |
| MousePheno | absent right subclavian artery | 2.97e-04 | 3 | 140 | 2 | MP:0010486 | |
| MousePheno | abnormal circulating glucocorticoid level | 3.01e-04 | 91 | 140 | 6 | MP:0003366 | |
| MousePheno | abnormal physiological response to xenobiotic | ABCC1 DRD2 NPY1R DRD3 HTR4 HTR7 GPR37 FPR2 LEMD2 SLC5A7 GRM7 GRM8 S1PR1 FADS1 ADRB1 ADRB3 KCNA5 | 3.33e-04 | 662 | 140 | 17 | MP:0008872 |
| MousePheno | abnormal corticosterone level | 3.58e-04 | 94 | 140 | 6 | MP:0003963 | |
| MousePheno | increased susceptibility to xenobiotic induced morbidity/mortality | 3.79e-04 | 133 | 140 | 7 | MP:0009766 | |
| MousePheno | abnormal alcohol consumption | 3.96e-04 | 35 | 140 | 4 | MP:0001425 | |
| MousePheno | abnormal touch/ nociception | ABCC3 GPR3 HTR1F HTR7 SLC5A7 GRM5 GRM7 CHRNB2 OPRL1 SLC6A9 KCNA1 KCNA6 | 3.98e-04 | 376 | 140 | 12 | MP:0001968 |
| MousePheno | decreased startle reflex | 4.23e-04 | 224 | 140 | 9 | MP:0001489 | |
| MousePheno | abnormal fluid intake | 4.34e-04 | 136 | 140 | 7 | MP:0011947 | |
| MousePheno | abnormal nervous system electrophysiology | DRD2 DRD4 MCHR1 GRM5 CHRNB2 KCNK18 SLC6A9 KCNA1 KCNA2 KCNA5 PLP1 | 4.73e-04 | 329 | 140 | 11 | MP:0002272 |
| MousePheno | decreased alcohol consumption | 5.00e-04 | 16 | 140 | 3 | MP:0003546 | |
| MousePheno | abnormal heartbeat | DRD2 NPY1R SLC4A7 MCHR1 AVPR1A MC2R SLC8A1 ADRA1A ADRA2A KCNA1 ADRB2 SLC30A5 KCNA7 RXFP2 | 5.01e-04 | 501 | 140 | 14 | MP:0004085 |
| MousePheno | enhanced coordination | 5.46e-04 | 38 | 140 | 4 | MP:0003858 | |
| MousePheno | abnormal catecholamine level | 5.62e-04 | 142 | 140 | 7 | MP:0011479 | |
| MousePheno | absent Meckel's cartilage | 5.90e-04 | 4 | 140 | 2 | MP:0004439 | |
| MousePheno | abnormal inhibitory postsynaptic currents | 6.73e-04 | 70 | 140 | 5 | MP:0002945 | |
| MousePheno | abnormal systemic arterial blood pressure | 8.05e-04 | 245 | 140 | 9 | MP:0000230 | |
| Domain | 7tm_1 | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 SSTR5 OPN1SW S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 | 8.08e-50 | 677 | 161 | 64 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 SSTR5 OPN1SW S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 | 1.70e-49 | 685 | 161 | 64 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 SSTR5 OPN1SW S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 | 2.96e-49 | 691 | 161 | 64 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 TAAR3P CCRL2 GPR63 RXFP3 SSTR5 OPN1SW S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 | 3.25e-49 | 692 | 161 | 64 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D OR9A4 HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 OR4K13 GPR31 GPR32 AVPR1A OR6K2 AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R LGR4 TAAR2 CCRL2 GPR63 RXFP3 SSTR5 OPN1SW S1PR1 GRPR S1PR3 OR6M1 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B OR56A5 HRH4 MRGPRX4 TAAR9 ACKR2 RXFP1 OR56A4 OR56A1 | 8.05e-49 | 670 | 161 | 63 | IPR017452 |
| Domain | 7TM_GPCR_Srsx | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 GPR50 TRHR MC2R MC3R TAAR2 SSTR5 S1PR1 GRPR S1PR3 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 MTNR1A MTNR1B TAAR9 OR56A1 | 1.44e-33 | 112 | 161 | 28 | SM01381 |
| Domain | ADR_fam | 1.13e-15 | 10 | 161 | 8 | IPR002233 | |
| Domain | K_chnl_volt-dep_Kv1 | 2.46e-14 | 8 | 161 | 7 | IPR003972 | |
| Domain | K_chnl_volt-dep_Kv | 4.94e-11 | 27 | 161 | 8 | IPR003968 | |
| Domain | VG_K_chnl | 2.96e-10 | 33 | 161 | 8 | IPR028325 | |
| Domain | BTB_2 | 1.63e-08 | 53 | 161 | 8 | PF02214 | |
| Domain | T1-type_BTB | 1.63e-08 | 53 | 161 | 8 | IPR003131 | |
| Domain | Vasoprsn_rcpt | 2.64e-08 | 5 | 161 | 4 | IPR001817 | |
| Domain | Channel_four-helix_dom | 2.96e-08 | 57 | 161 | 8 | IPR027359 | |
| Domain | - | 2.96e-08 | 57 | 161 | 8 | 1.20.120.350 | |
| Domain | GPCR_3_mtglu_rcpt | 3.62e-07 | 8 | 161 | 4 | IPR000162 | |
| Domain | Na_Ca_Ex | 6.29e-07 | 3 | 161 | 3 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 6.29e-07 | 3 | 161 | 3 | IPR032452 | |
| Domain | Na_Ca_ex_C | 6.29e-07 | 3 | 161 | 3 | PF16494 | |
| Domain | Melatonin_rcpt | 6.29e-07 | 3 | 161 | 3 | IPR000025 | |
| Domain | 5HT_rcpt | 6.48e-07 | 9 | 161 | 4 | IPR002231 | |
| Domain | Formyl_rcpt-rel | 1.07e-06 | 10 | 161 | 4 | IPR000826 | |
| Domain | ABC_tran | 3.40e-06 | 48 | 161 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.40e-06 | 48 | 161 | 6 | PS50893 | |
| Domain | NCD3G | 3.58e-06 | 13 | 161 | 4 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 3.58e-06 | 13 | 161 | 4 | IPR011500 | |
| Domain | ABC_TRANSPORTER_1 | 3.85e-06 | 49 | 161 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 4.34e-06 | 50 | 161 | 6 | IPR003439 | |
| Domain | GPCR_3_CS | 4.98e-06 | 14 | 161 | 4 | IPR017979 | |
| Domain | Dopamine_rcpt | 6.21e-06 | 5 | 161 | 3 | IPR000929 | |
| Domain | Ion_trans_dom | 6.50e-06 | 114 | 161 | 8 | IPR005821 | |
| Domain | Ion_trans | 6.50e-06 | 114 | 161 | 8 | PF00520 | |
| Domain | Chemokine_rcpt | 8.93e-06 | 16 | 161 | 4 | IPR000355 | |
| Domain | Melcrt_ACTH_rcpt | 1.23e-05 | 6 | 161 | 3 | IPR001671 | |
| Domain | ANF_lig-bd_rcpt | 1.56e-05 | 37 | 161 | 5 | IPR001828 | |
| Domain | ANF_receptor | 1.56e-05 | 37 | 161 | 5 | PF01094 | |
| Domain | Peripla_BP_I | 2.03e-05 | 39 | 161 | 5 | IPR028082 | |
| Domain | TAAR_fam | 2.15e-05 | 7 | 161 | 3 | IPR009132 | |
| Domain | BTB | 2.67e-05 | 180 | 161 | 9 | SM00225 | |
| Domain | GPCR_3 | 2.84e-05 | 21 | 161 | 4 | IPR000337 | |
| Domain | BTB/POZ_dom | 3.31e-05 | 185 | 161 | 9 | IPR000210 | |
| Domain | Calx_beta | 3.41e-05 | 8 | 161 | 3 | SM00237 | |
| Domain | 7tm_3 | 3.45e-05 | 22 | 161 | 4 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.45e-05 | 22 | 161 | 4 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.45e-05 | 22 | 161 | 4 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.45e-05 | 22 | 161 | 4 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.45e-05 | 22 | 161 | 4 | PS50259 | |
| Domain | GPCR_3_C | 3.45e-05 | 22 | 161 | 4 | IPR017978 | |
| Domain | SKP1/BTB/POZ | 3.92e-05 | 189 | 161 | 9 | IPR011333 | |
| Domain | ABC_membrane | 4.94e-05 | 24 | 161 | 4 | PF00664 | |
| Domain | Calx_beta | 5.08e-05 | 9 | 161 | 3 | IPR003644 | |
| Domain | NaCa_Exmemb | 5.08e-05 | 9 | 161 | 3 | IPR004837 | |
| Domain | Na_Ca_ex | 5.08e-05 | 9 | 161 | 3 | PF01699 | |
| Domain | Calx-beta | 5.08e-05 | 9 | 161 | 3 | PF03160 | |
| Domain | EDG1_rcpt | 7.39e-05 | 2 | 161 | 2 | IPR000987 | |
| Domain | Relaxin_rcpt | 7.39e-05 | 2 | 161 | 2 | IPR008112 | |
| Domain | DUF1856 | 7.39e-05 | 2 | 161 | 2 | IPR015076 | |
| Domain | Prominin | 7.39e-05 | 2 | 161 | 2 | IPR008795 | |
| Domain | Mel_1A_rcpt | 7.39e-05 | 2 | 161 | 2 | IPR002278 | |
| Domain | DUF1856 | 7.39e-05 | 2 | 161 | 2 | SM01164 | |
| Domain | DUF1856 | 7.39e-05 | 2 | 161 | 2 | PF08983 | |
| Domain | Prominin | 7.39e-05 | 2 | 161 | 2 | PF05478 | |
| Domain | ABC_TM1F | 9.27e-05 | 28 | 161 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 9.27e-05 | 28 | 161 | 4 | IPR011527 | |
| Domain | Multidrug-R_assoc | 4.38e-04 | 4 | 161 | 2 | IPR005292 | |
| Domain | ABC_transporter_CS | 4.61e-04 | 42 | 161 | 4 | IPR017871 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.66e-04 | 18 | 161 | 3 | PS00754 | |
| Domain | SNF | 5.50e-04 | 19 | 161 | 3 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.50e-04 | 19 | 161 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.50e-04 | 19 | 161 | 3 | PS50267 | |
| Domain | Na/ntran_symport | 5.50e-04 | 19 | 161 | 3 | IPR000175 | |
| Domain | SCAMP | 7.26e-04 | 5 | 161 | 2 | IPR007273 | |
| Domain | S1P_rcpt | 7.26e-04 | 5 | 161 | 2 | IPR004061 | |
| Domain | SCAMP | 7.26e-04 | 5 | 161 | 2 | PF04144 | |
| Domain | Yip1 | 1.51e-03 | 7 | 161 | 2 | PF04893 | |
| Domain | CXCR4/ACKR2 | 1.51e-03 | 7 | 161 | 2 | IPR001277 | |
| Domain | Yip1 | 1.51e-03 | 7 | 161 | 2 | IPR006977 | |
| Domain | AAA+_ATPase | 1.57e-03 | 144 | 161 | 6 | IPR003593 | |
| Domain | AAA | 1.57e-03 | 144 | 161 | 6 | SM00382 | |
| Domain | ABC_A | 4.61e-03 | 12 | 161 | 2 | IPR026082 | |
| Domain | Glyco_trans_31 | 8.19e-03 | 16 | 161 | 2 | IPR002659 | |
| Domain | Galactosyl_T | 8.19e-03 | 16 | 161 | 2 | PF01762 | |
| Domain | Nicotinic_acetylcholine_rcpt | 8.19e-03 | 16 | 161 | 2 | IPR002394 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 TAAR3P CCRL2 RXFP3 ADGRE2 ECE1 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 TAS2R50 | 7.69e-53 | 430 | 139 | 59 | MM15160 |
| Pathway | WP_GPCRS_NONODORANT | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 AVPR1A AVPR1B AVPR2 FPR1 MC2R MC3R CCRL2 RXFP3 ADGRE2 SSTR5 GRM5 GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 EDNRA ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 ACKR2 RXFP1 | 2.41e-51 | 266 | 139 | 50 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 CCRL2 RXFP3 ADGRE2 ECE1 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 TAS2R50 | 1.66e-49 | 463 | 139 | 58 | M507 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 AVPR1A AVPR1B AVPR2 FPR1 FPR2 MC2R MC3R TAAR2 GRID1 SSTR5 GRM5 GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 EDNRA CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 RXFP1 | 2.72e-49 | 272 | 139 | 49 | M13380 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 TAAR3P CCRL2 RXFP3 ECE1 SSTR5 OPN1SW S1PR1 GRPR S1PR3 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 | 4.25e-49 | 333 | 139 | 52 | MM14963 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 CCRL2 RXFP3 ECE1 SSTR5 OPN1SW S1PR1 GRPR S1PR3 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 | 7.54e-48 | 330 | 139 | 51 | M18334 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR3 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 GPR50 TRHR HTR5A HTR7 GPER1 GPR31 GPR32 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R CCRL2 GPR63 SSTR5 OPN1SW GRPR EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR4 MTNR1A MTNR1B ACKR2 | 3.08e-44 | 260 | 139 | 45 | M39397 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 TAAR3P CCRL2 RXFP3 ADGRE2 ECE1 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 TAS2R50 | 1.45e-43 | 646 | 139 | 60 | MM14962 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR3 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 GPR50 TRHR HTR5A HTR7 GPER1 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R CCRL2 GPR63 SSTR5 OPN1SW GRPR OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR4 MTNR1A ACKR2 | 1.29e-41 | 186 | 139 | 39 | MM15994 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 TRHR HTR5A HTR7 GPER1 GPR31 GPR32 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R TAAR2 CCRL2 RXFP3 ADGRE2 ECE1 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 S1PR1 GRPR S1PR3 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B TAS2R14 ADRB1 ADRB2 ADRB3 OXTR P2RY4 CXCR6 CXCR4 RXFP2 MTNR1A MTNR1B HRH4 TAAR9 ACKR2 RXFP1 TAS2R50 | 1.94e-41 | 702 | 139 | 60 | M746 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 TAAR2 TAAR3P ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 TAAR9 | 7.83e-30 | 42 | 139 | 20 | MM14971 |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 TAAR2 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 TAAR9 | 7.91e-28 | 42 | 139 | 19 | M5868 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR5A GPER1 GPR31 GPR37 FPR1 FPR2 RXFP3 SSTR5 OPN1SW GRM6 GRM7 GRM8 S1PR3 ADCY7 OPRL1 ADRA2A ADRA2B TAS2R14 P2RY4 CXCR6 CXCR4 MTNR1A MTNR1B HRH4 TAS2R50 | 7.23e-25 | 289 | 139 | 32 | MM15057 |
| Pathway | WP_MONOAMINE_GPCRS | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 8.72e-25 | 31 | 139 | 16 | MM15871 |
| Pathway | WP_MONOAMINE_GPCRS | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.33e-24 | 33 | 139 | 16 | M39585 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR5A GPER1 GPR31 GPR37 FPR1 FPR2 RXFP3 SSTR5 OPN1SW GRM6 GRM7 GRM8 S1PR3 ADCY7 OPRL1 ADRA2A ADRA2B TAS2R14 P2RY4 CXCR6 CXCR4 MTNR1A MTNR1B HRH4 TAS2R50 | 9.87e-24 | 314 | 139 | 32 | M600 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | NPY1R MCHR1 TRHR GPER1 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R CCRL2 RXFP3 ECE1 SSTR5 GRPR EDNRA OPRL1 OXTR CXCR6 CXCR4 RXFP2 ACKR2 RXFP1 | 5.65e-21 | 197 | 139 | 25 | M12289 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | NPY1R MCHR1 TRHR GPER1 AVPR1A AVPR1B AVPR2 GPR37 FPR1 FPR2 MC2R MC3R CCRL2 RXFP3 ECE1 SSTR5 GRPR EDNRA OPRL1 OXTR CXCR6 CXCR4 RXFP2 ACKR2 RXFP1 | 5.65e-21 | 197 | 139 | 25 | MM14970 |
| Pathway | WP_GPCRS_PEPTIDE | NPY1R TRHR AVPR1A AVPR1B AVPR2 FPR1 FPR2 MC2R MC3R SSTR5 GRPR EDNRA OPRL1 OXTR CXCR6 CXCR4 | 5.21e-18 | 70 | 139 | 16 | MM15959 |
| Pathway | WP_PEPTIDE_GPCRS | NPY1R TRHR AVPR1A AVPR1B AVPR2 FPR1 FPR2 MC2R MC3R SSTR5 GRPR EDNRA OPRL1 OXTR CXCR6 CXCR4 | 1.72e-17 | 75 | 139 | 16 | M39696 |
| Pathway | WP_GPCRS_OTHER | DRD3 DRD4 HTR1F HTR7 TAAR2 TAAR3P RXFP3 ADGRE2 GRM8 S1PR1 GRPR EDNRA ADRA1D ADRB2 HRH4 RXFP1 ALG6 | 2.65e-17 | 93 | 139 | 17 | M39629 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | HTR4 TRHR HTR5A HTR7 AVPR1A AVPR1B GRM5 GRPR ADCY7 EDNRA SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA1A ADRB1 ADRB2 ADRB3 OXTR | 1.01e-14 | 178 | 139 | 19 | M2890 |
| Pathway | REACTOME_ADRENOCEPTORS | 2.76e-13 | 9 | 139 | 7 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 2.76e-13 | 9 | 139 | 7 | MM15009 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | HTR4 HTR7 GPER1 GPR32 AVPR2 MC2R MC3R TAAR2 ADCY7 ADRB1 ADRB2 ADRB3 RXFP2 TAAR9 RXFP1 | 3.81e-11 | 157 | 139 | 15 | M4904 |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.60e-11 | 50 | 139 | 10 | M47951 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | HTR4 HTR7 GPER1 AVPR2 MC2R MC3R TAAR2 TAAR3P ADRB1 ADRB2 ADRB3 RXFP2 TAAR9 RXFP1 | 1.27e-10 | 143 | 139 | 14 | MM15055 |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 3.66e-10 | 11 | 139 | 6 | MM15008 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | DRD2 DRD4 HTR1D HTR1F HTR4 HTR7 GRM5 GRM6 GRM7 GRM8 ADRA1D ADRA1A KCNA1 KCNA2 ADRB2 KCNA3 OXTR KCNA5 KCNA6 KCNA7 | 5.13e-10 | 367 | 139 | 20 | M48346 |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 7.26e-10 | 12 | 139 | 6 | M6034 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 3.10e-09 | 98 | 139 | 11 | MM14545 |
| Pathway | WP_GPCRS_ODORANT | GPR3 GPR31 GPR37 LGR4 TAAR2 TAAR3P GPR63 OPN1SW OPRL1 TAS2R14 MRGPRX4 TAAR9 TAS2R50 | 4.78e-09 | 157 | 139 | 13 | MM15872 |
| Pathway | REACTOME_POTASSIUM_CHANNELS | KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 5.29e-09 | 103 | 139 | 11 | M1073 |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 5.30e-09 | 41 | 139 | 8 | MM14546 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 6.09e-09 | 16 | 139 | 6 | M39849 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 7.91e-09 | 43 | 139 | 8 | M1056 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA6 SLC5A7 GRM5 ADCY7 CHRNB2 KCNK18 SLC6A13 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 3.24e-08 | 335 | 139 | 17 | MM14503 |
| Pathway | WP_GPCRS_OTHER | DRD2 HTR1D ADGRE2 SSTR5 S1PR1 EDNRA OPRL1 ADRB1 ADRB2 MTNR1B | 3.44e-08 | 96 | 139 | 10 | MM15939 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC4A7 SLC5A7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC20A1 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 9.42e-08 | 238 | 139 | 14 | MM15076 |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.34e-07 | 6 | 139 | 4 | M27289 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.34e-07 | 6 | 139 | 4 | MM14989 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC4A7 SLC5A7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC20A1 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 1.65e-07 | 249 | 139 | 14 | M5988 |
| Pathway | REACTOME_NEURONAL_SYSTEM | CHRNA6 SLC5A7 GRM5 ADCY7 CHRNB2 KCNK18 SLC6A13 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCC8 | 6.02e-07 | 411 | 139 | 17 | M735 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC5A7 SLC6A9 SLC6A13 SLC30A5 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 7.83e-07 | 76 | 139 | 8 | MM15072 |
| Pathway | WP_SMALL_LIGAND_GPCRS | 9.02e-07 | 19 | 139 | 5 | M39728 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.49e-06 | 37 | 139 | 6 | MM15067 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 1.55e-06 | 21 | 139 | 5 | M39343 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC5A7 SLC6A9 SLC6A13 SLC30A5 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 1.69e-06 | 84 | 139 | 8 | M27334 |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 2.06e-06 | 39 | 139 | 6 | M793 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.28e-06 | 44 | 139 | 6 | M11911 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | MCHR1 TRHR AVPR1A AVPR1B FPR2 GRM5 GRPR EDNRA ADRA1D ADRA1A OXTR | 7.29e-06 | 210 | 139 | 11 | MM15043 |
| Pathway | BIOCARTA_MRP_PATHWAY | 9.25e-06 | 5 | 139 | 3 | MM1586 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 9.25e-06 | 5 | 139 | 3 | M27301 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 9.25e-06 | 5 | 139 | 3 | MM15007 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | MCHR1 TRHR AVPR1A AVPR1B FPR2 GRM5 GRPR EDNRA ADRA1D ADRA1A OXTR | 9.95e-06 | 217 | 139 | 11 | M18437 |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.14e-05 | 15 | 139 | 4 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 1.14e-05 | 15 | 139 | 4 | MM15845 | |
| Pathway | WP_ENDOTHELIN_PATHWAYS | 1.65e-05 | 33 | 139 | 5 | M39651 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 1.84e-05 | 6 | 139 | 3 | M22078 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 2.49e-05 | 18 | 139 | 4 | MM15858 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 3.00e-05 | 201 | 139 | 10 | M39605 | |
| Pathway | WP_SLEEP_REGULATION | 3.35e-05 | 38 | 139 | 5 | M39504 | |
| Pathway | REACTOME_RELAXIN_RECEPTORS | 5.07e-05 | 8 | 139 | 3 | M27371 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.03e-04 | 147 | 139 | 8 | MM15854 | |
| Pathway | REACTOME_RELAXIN_RECEPTORS | 1.07e-04 | 10 | 139 | 3 | MM15111 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 ABCC1 SLC4A7 AVPR2 SLC5A7 ABCA9 ADCY7 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC20A1 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 1.10e-04 | 736 | 139 | 19 | M27287 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.24e-04 | 151 | 139 | 8 | M39329 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ABCC3 ABCC1 SLC4A7 AVPR2 SLC5A7 ABCA9 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC20A1 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 1.27e-04 | 681 | 139 | 18 | MM14985 |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 1.46e-04 | 11 | 139 | 3 | M27336 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.93e-04 | 12 | 139 | 3 | M27326 | |
| Pathway | BIOCARTA_BARRESTIN_PATHWAY | 1.93e-04 | 12 | 139 | 3 | M7772 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.50e-04 | 13 | 139 | 3 | MM15078 | |
| Pathway | BIOCARTA_BARR_MAPK_PATHWAY | 3.15e-04 | 14 | 139 | 3 | M668 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.15e-04 | 14 | 139 | 3 | MM15052 | |
| Pathway | WP_MELATONIN_METABOLISM_AND_EFFECTS | 4.64e-04 | 37 | 139 | 4 | M39418 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.39e-04 | 103 | 139 | 6 | MM15196 | |
| Pathway | BIOCARTA_BARRESTIN_SRC_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M111 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 6.93e-04 | 108 | 139 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 7.27e-04 | 109 | 139 | 6 | MM15074 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 8.10e-04 | 19 | 139 | 3 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 8.10e-04 | 19 | 139 | 3 | MM15107 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 9.63e-04 | 115 | 139 | 6 | M9387 | |
| Pathway | PID_S1P_META_PATHWAY | 1.10e-03 | 21 | 139 | 3 | M155 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.16e-03 | 47 | 139 | 4 | M42524 | |
| Pathway | WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2 | 1.41e-03 | 6 | 139 | 2 | M42575 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.81e-03 | 130 | 139 | 6 | M27454 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.86e-03 | 177 | 139 | 7 | M27476 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.31e-03 | 27 | 139 | 3 | MM15053 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 2.39e-03 | 57 | 139 | 4 | M625 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 2.54e-03 | 58 | 139 | 4 | MM14978 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.57e-03 | 28 | 139 | 3 | M924 | |
| Pathway | REACTOME_LINOLEIC_ACID_LA_METABOLISM | 2.60e-03 | 8 | 139 | 2 | MM14822 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 2.60e-03 | 8 | 139 | 2 | M48022 | |
| Pathway | REACTOME_LINOLEIC_ACID_LA_METABOLISM | 2.60e-03 | 8 | 139 | 2 | M27115 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 2.60e-03 | 8 | 139 | 2 | M27370 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 2.60e-03 | 8 | 139 | 2 | MM15110 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 2.84e-03 | 29 | 139 | 3 | M55 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.96e-03 | 99 | 139 | 5 | M27474 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.32e-03 | 9 | 139 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.32e-03 | 9 | 139 | 2 | MM15313 | |
| Pubmed | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPER1 AVPR1A AVPR1B AVPR2 TAAR2 TAAR3P SSTR5 OPN1SW GRPR OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 P2RY4 CXCR6 CXCR4 HRH4 TAAR9 | 1.21e-37 | 200 | 169 | 31 | 18240029 | |
| Pubmed | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 HTR5A HTR7 AVPR1B FPR1 MC3R SSTR5 S1PR1 S1PR3 EDNRA OPRL1 ADRA2A P2RY4 CXCR6 CXCR4 MTNR1A MTNR1B HRH4 | 7.07e-31 | 179 | 169 | 26 | 18577758 | |
| Pubmed | CHRNA6 DRD2 HTR1B HTR1D HTR1F HTR4 TRHR HTR5A HTR7 AVPR1A AVPR2 GRM5 GRM6 GRM7 CHRNB2 SLC6A9 SLC6A13 ADRA1D ADRA1A ADRA2A ADRB1 ADRB2 OXTR SLC6A5 | 3.18e-22 | 300 | 169 | 24 | 19086053 | |
| Pubmed | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1F HTR5A FPR1 RXFP3 SSTR5 S1PR1 S1PR3 OPRL1 CXCR4 MTNR1A | 1.87e-20 | 75 | 169 | 15 | 2834384 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GRM5 GRM6 GRM7 GRM8 CHRNB2 HRH4 | 7.10e-19 | 118 | 169 | 16 | 19156168 |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | DRD2 NPY1R DRD3 DRD4 HTR1B AVPR1A AVPR1B ADCY7 CHRNB2 OPRL1 SLC6A13 ADRA1A ADRA2A ADRA2B ADRB2 | 1.10e-16 | 130 | 169 | 15 | 19874574 |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR5A HTR7 AVPR1A MC3R SSTR5 GRM5 ADRA2A ADRB1 ADRB2 ADRB3 | 8.21e-16 | 182 | 169 | 16 | 20468064 |
| Pubmed | Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. | 2.02e-15 | 9 | 169 | 7 | 21209093 | |
| Pubmed | 1.20e-14 | 6 | 169 | 6 | 20044737 | ||
| Pubmed | Physical mapping of potassium channel gene clusters on mouse chromosomes three and six. | 1.20e-14 | 6 | 169 | 6 | 9286706 | |
| Pubmed | 8.39e-14 | 7 | 169 | 6 | 20705341 | ||
| Pubmed | 2.39e-13 | 58 | 169 | 10 | 11140838 | ||
| Pubmed | Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. | 3.34e-13 | 8 | 169 | 6 | 9139936 | |
| Pubmed | 7.53e-13 | 28 | 169 | 8 | 19352218 | ||
| Pubmed | 1.73e-12 | 70 | 169 | 10 | 12036966 | ||
| Pubmed | Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome. | 1.89e-12 | 31 | 169 | 8 | 8034307 | |
| Pubmed | 2.55e-12 | 5 | 169 | 5 | 21233214 | ||
| Pubmed | 1.77e-11 | 40 | 169 | 8 | 16382104 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | DRD2 NPY1R DRD3 DRD4 HTR1B MCHR1 ABCA13 MC3R GRM8 OPRL1 ADRA2A | 3.83e-11 | 128 | 169 | 11 | 19058789 |
| Pubmed | 9.26e-11 | 16 | 169 | 6 | 15824464 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | KCNK18 SLC8A1 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNC4 KCNJ2 ABCC8 | 9.38e-11 | 139 | 169 | 11 | 16985003 |
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 2.13e-10 | 18 | 169 | 6 | 19455600 | |
| Pubmed | 3.17e-10 | 9 | 169 | 5 | 9488722 | ||
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 11955056 | ||
| Pubmed | Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. | 5.38e-10 | 4 | 169 | 4 | 17512307 | |
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 18331634 | ||
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 12519093 | ||
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 27206969 | ||
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 24249731 | ||
| Pubmed | Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells. | 6.31e-10 | 10 | 169 | 5 | 1383027 | |
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 1.00e-09 | 95 | 169 | 9 | 16754659 | |
| Pubmed | A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. | 1.98e-09 | 25 | 169 | 6 | 12544508 | |
| Pubmed | 2.56e-09 | 26 | 169 | 6 | 7905852 | ||
| Pubmed | Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance. | 2.68e-09 | 5 | 169 | 4 | 15719258 | |
| Pubmed | The central melanocortin system directly controls peripheral lipid metabolism. | 2.68e-09 | 5 | 169 | 4 | 17885689 | |
| Pubmed | 2.68e-09 | 5 | 169 | 4 | 2154750 | ||
| Pubmed | Molecular pharmacology and modeling of vasopressin receptors. | 2.68e-09 | 5 | 169 | 4 | 12436935 | |
| Pubmed | DRD2 DRD3 DRD4 HTR1D HTR7 MC3R ADRA2A ADRB1 ADRB2 ADRB3 ABCC8 | 2.94e-09 | 192 | 169 | 11 | 20602615 | |
| Pubmed | 3.18e-09 | 13 | 169 | 5 | 26531127 | ||
| Pubmed | 4.15e-09 | 28 | 169 | 6 | 19737523 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 5.12e-09 | 79 | 169 | 8 | 12679517 | |
| Pubmed | 6.26e-09 | 81 | 169 | 8 | 22723691 | ||
| Pubmed | A candidate gene study of obstructive sleep apnea in European Americans and African Americans. | 6.28e-09 | 52 | 169 | 7 | 20538960 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 12184796 | ||
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 10858434 | ||
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 28862946 | ||
| Pubmed | Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes. | 8.01e-09 | 6 | 169 | 4 | 17636168 | |
| Pubmed | Functional activity of serotoninergic and melatoninergic systems expressed in the skin. | 8.01e-09 | 6 | 169 | 4 | 12767050 | |
| Pubmed | Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. | 8.01e-09 | 6 | 169 | 4 | 14686897 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | DRD2 HTR4 HTR5A GPR37 MC2R ELOVL5 RXFP3 PIGU OPRL1 SLC8A2 ADRA1A ADRB2 OXTR TM9SF2 YIPF1 ABCC8 MTNR1A PLP1 | 1.01e-08 | 697 | 169 | 18 | 28298427 |
| Pubmed | 1.74e-08 | 35 | 169 | 6 | 28031476 | ||
| Pubmed | Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. | 1.86e-08 | 7 | 169 | 4 | 12627464 | |
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 27619418 | ||
| Pubmed | 2.08e-08 | 18 | 169 | 5 | 19506906 | ||
| Pubmed | Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. | 3.71e-08 | 8 | 169 | 4 | 11854302 | |
| Pubmed | 3.71e-08 | 8 | 169 | 4 | 12435606 | ||
| Pubmed | 3.84e-08 | 67 | 169 | 7 | 20398908 | ||
| Pubmed | 4.88e-08 | 21 | 169 | 5 | 15452121 | ||
| Pubmed | 4.88e-08 | 21 | 169 | 5 | 18270970 | ||
| Pubmed | 6.65e-08 | 9 | 169 | 4 | 19056576 | ||
| Pubmed | 6.65e-08 | 9 | 169 | 4 | 18821566 | ||
| Pubmed | 1.01e-07 | 24 | 169 | 5 | 15561968 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 1.10e-07 | 10 | 169 | 4 | 9069281 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 18801900 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 28752049 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 24885710 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 9322919 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 15479221 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 12110114 | ||
| Pubmed | betaAR signaling required for diet-induced thermogenesis and obesity resistance. | 1.13e-07 | 3 | 169 | 3 | 12161655 | |
| Pubmed | Role of β-adrenoceptors in glucose uptake in astrocytes using β-adrenoceptor knockout mice. | 1.13e-07 | 3 | 169 | 3 | 21138422 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 26566631 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 15939803 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 23473322 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 33669857 | ||
| Pubmed | Norepinephrine induces lipolysis in beta1/beta2/beta3-adrenoceptor knockout mice. | 1.13e-07 | 3 | 169 | 3 | 15939797 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 31936298 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 21382638 | ||
| Pubmed | Association between body fat response to exercise training and multilocus ADR genotypes. | 1.13e-07 | 3 | 169 | 3 | 15166301 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 17345787 | ||
| Pubmed | Genetic polymorphisms at the rat and murine loci coding for dopamine D2-like receptors. | 1.13e-07 | 3 | 169 | 3 | 7609622 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 16767221 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 10341260 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 21540189 | ||
| Pubmed | Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. | 1.13e-07 | 3 | 169 | 3 | 18311486 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 11737201 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 17634333 | ||
| Pubmed | The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer. | 1.13e-07 | 3 | 169 | 3 | 34127021 | |
| Pubmed | Diverse evolutionary histories for beta-adrenoreceptor genes in humans. | 1.13e-07 | 3 | 169 | 3 | 19576569 | |
| Pubmed | Expression of beta adrenergic receptors in mouse oocytes and preimplantation embryos. | 1.13e-07 | 3 | 169 | 3 | 15791602 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 8413587 | ||
| Pubmed | Total beta-adrenoceptor deficiency results in cardiac hypotrophy and negative inotropy. | 1.13e-07 | 3 | 169 | 3 | 20406048 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 7738011 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 17407504 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 23133676 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 38900750 | ||
| Pubmed | Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. | 1.13e-07 | 3 | 169 | 3 | 15564898 | |
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 19275926 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 16728691 | ||
| Pubmed | D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD. | 1.13e-07 | 3 | 169 | 3 | 19840852 | |
| Interaction | DOLK interactions | 9.63e-09 | 55 | 156 | 8 | int:DOLK | |
| Interaction | YIPF3 interactions | ABCC1 DRD2 AVPR2 FPR2 ELOVL5 TMEM63B PIGU S1PR1 OXTR CXCR4 SLC6A5 ACKR2 | 2.37e-08 | 186 | 156 | 12 | int:YIPF3 |
| Interaction | CRELD1 interactions | ABCC3 DRD2 LEMD2 ELOVL5 TMEM104 PIGU SLC30A5 MACO1 MTNR1B FITM2 ALG6 | 5.85e-08 | 163 | 156 | 11 | int:CRELD1 |
| Interaction | GNAI1 interactions | DRD3 DRD4 GPR50 S1PR1 S1PR3 ADRA2A ADRB2 CXCR4 MTNR1A MTNR1B HRH4 | 9.56e-08 | 171 | 156 | 11 | int:GNAI1 |
| Interaction | SYNGR2 interactions | 1.17e-07 | 75 | 156 | 8 | int:SYNGR2 | |
| Interaction | ATP2B2 interactions | SLC4A7 AVPR2 FPR2 LEMD2 TMEM63B LGR4 S1PR1 IFNLR1 OPRL1 CXCR4 RXFP1 | 4.20e-07 | 198 | 156 | 11 | int:ATP2B2 |
| Interaction | PTDSS2 interactions | 4.47e-07 | 89 | 156 | 8 | int:PTDSS2 | |
| Interaction | KCNA2 interactions | 5.63e-07 | 125 | 156 | 9 | int:KCNA2 | |
| Interaction | CTAGE1 interactions | 7.00e-07 | 10 | 156 | 4 | int:CTAGE1 | |
| Interaction | LPAR1 interactions | ZDHHC18 DRD2 GPR50 SCAMP2 ADGRE2 PIGU SLC30A5 TM9SF2 CXCR4 FITM2 ALG6 | 7.53e-07 | 210 | 156 | 11 | int:LPAR1 |
| Interaction | GPRASP1 interactions | 8.57e-07 | 67 | 156 | 7 | int:GPRASP1 | |
| Interaction | SLC19A2 interactions | 1.05e-06 | 69 | 156 | 7 | int:SLC19A2 | |
| Interaction | TSPAN15 interactions | ZDHHC18 SCAMP1 LEMD2 TMEM63B LGR4 SCAMP2 ADGRE2 PIGU S1PR1 FADS1 SLC20A1 FITM2 | 1.68e-06 | 276 | 156 | 12 | int:TSPAN15 |
| Interaction | HTR1D interactions | 1.81e-06 | 4 | 156 | 3 | int:HTR1D | |
| Interaction | TMX2 interactions | ABCC1 FAXDC2 TVP23B YIPF2 KCNA2 KCNA5 YIPF1 TMX4 MTNR1A RXFP1 SFT2D1 | 2.08e-06 | 233 | 156 | 11 | int:TMX2 |
| Interaction | FADS1 interactions | 5.06e-06 | 87 | 156 | 7 | int:FADS1 | |
| Interaction | HTR4 interactions | 1.22e-05 | 19 | 156 | 4 | int:HTR4 | |
| Interaction | GOLM1 interactions | 1.75e-05 | 145 | 156 | 8 | int:GOLM1 | |
| Interaction | PIGN interactions | 1.85e-05 | 71 | 156 | 6 | int:PIGN | |
| Interaction | GPR42 interactions | 2.52e-05 | 111 | 156 | 7 | int:GPR42 | |
| Interaction | ARL5B interactions | 3.41e-05 | 79 | 156 | 6 | int:ARL5B | |
| Interaction | KCNJ9 interactions | 3.69e-05 | 9 | 156 | 3 | int:KCNJ9 | |
| Interaction | KCNA10 interactions | 3.85e-05 | 25 | 156 | 4 | int:KCNA10 | |
| Interaction | GPR21 interactions | 3.93e-05 | 81 | 156 | 6 | int:GPR21 | |
| Interaction | GPR37 interactions | 3.93e-05 | 81 | 156 | 6 | int:GPR37 | |
| Interaction | GPR89A interactions | 4.16e-05 | 120 | 156 | 7 | int:GPR89A | |
| Interaction | SLC35F5 interactions | 4.52e-05 | 26 | 156 | 4 | int:SLC35F5 | |
| Interaction | ATP2B3 interactions | 5.51e-05 | 86 | 156 | 6 | int:ATP2B3 | |
| Interaction | FAM241B interactions | 7.12e-05 | 90 | 156 | 6 | int:FAM241B | |
| Interaction | CDS1 interactions | 7.24e-05 | 56 | 156 | 5 | int:CDS1 | |
| Interaction | SYNJ2BP interactions | 7.28e-05 | 131 | 156 | 7 | int:SYNJ2BP | |
| Interaction | YIPF5 interactions | 8.01e-05 | 133 | 156 | 7 | int:YIPF5 | |
| Interaction | GPR50 interactions | 8.58e-05 | 58 | 156 | 5 | int:GPR50 | |
| Interaction | LRRC8C interactions | 9.24e-05 | 31 | 156 | 4 | int:LRRC8C | |
| Interaction | AVP interactions | 9.24e-05 | 31 | 156 | 4 | int:AVP | |
| Interaction | SURF4 interactions | 9.52e-05 | 184 | 156 | 8 | int:SURF4 | |
| Interaction | KCNA5 interactions | 1.01e-04 | 60 | 156 | 5 | int:KCNA5 | |
| Interaction | TSPAN7 interactions | 1.05e-04 | 32 | 156 | 4 | int:TSPAN7 | |
| Interaction | TVP23B interactions | 1.05e-04 | 32 | 156 | 4 | int:TVP23B | |
| Interaction | KCNAB2 interactions | 1.18e-04 | 62 | 156 | 5 | int:KCNAB2 | |
| Interaction | HTR1A interactions | 1.19e-04 | 33 | 156 | 4 | int:HTR1A | |
| Interaction | TTYH1 interactions | ZDHHC18 DRD2 SLC4A7 GPR50 GPR37 LEMD2 TMEM63B FADS1 MACO1 FITM2 | 1.19e-04 | 300 | 156 | 10 | int:TTYH1 |
| Interaction | VKORC1L1 interactions | 1.21e-04 | 99 | 156 | 6 | int:VKORC1L1 | |
| Interaction | TMEFF2 interactions | 1.23e-04 | 13 | 156 | 3 | int:TMEFF2 | |
| Interaction | NTSR1 interactions | 1.28e-04 | 63 | 156 | 5 | int:NTSR1 | |
| Interaction | REEP4 interactions | 1.33e-04 | 193 | 156 | 8 | int:REEP4 | |
| Interaction | TLCD4 interactions | 1.35e-04 | 101 | 156 | 6 | int:TLCD4 | |
| Interaction | NAT14 interactions | 1.48e-04 | 65 | 156 | 5 | int:NAT14 | |
| Interaction | CHPT1 interactions | 1.48e-04 | 65 | 156 | 5 | int:CHPT1 | |
| Interaction | LMBRD2 interactions | 1.48e-04 | 65 | 156 | 5 | int:LMBRD2 | |
| Interaction | KCNA1 interactions | 1.50e-04 | 35 | 156 | 4 | int:KCNA1 | |
| Interaction | CERS6 interactions | 1.59e-04 | 104 | 156 | 6 | int:CERS6 | |
| Interaction | CAV1 interactions | ABCC1 DRD2 SLC4A7 HTR1F MBOAT1 SCAMP1 ELOVL5 TMEM63B ECE1 S1PR1 KCNA3 KCNA5 MLC1 CXCR4 USP6NL VPS13B | 1.61e-04 | 724 | 156 | 16 | int:CAV1 |
| Interaction | ABCC10 interactions | 1.68e-04 | 36 | 156 | 4 | int:ABCC10 | |
| Interaction | TAAR9 interactions | 1.78e-04 | 3 | 156 | 2 | int:TAAR9 | |
| Interaction | KCNC4 interactions | 1.87e-04 | 37 | 156 | 4 | int:KCNC4 | |
| Interaction | FFAR3 interactions | 1.93e-04 | 15 | 156 | 3 | int:FFAR3 | |
| Interaction | SLC8A2 interactions | 1.93e-04 | 15 | 156 | 3 | int:SLC8A2 | |
| Interaction | DLG4 interactions | DRD2 SLC4A7 GRID1 GRM7 KCNA1 ADRB1 KCNA2 KCNA3 KCNA5 KCNA6 KCNJ2 PLP1 | 2.01e-04 | 449 | 156 | 12 | int:DLG4 |
| Interaction | SLC30A6 interactions | 2.05e-04 | 109 | 156 | 6 | int:SLC30A6 | |
| Interaction | ABCD4 interactions | 2.54e-04 | 40 | 156 | 4 | int:ABCD4 | |
| Interaction | SLC41A1 interactions | 2.54e-04 | 40 | 156 | 4 | int:SLC41A1 | |
| Interaction | MZT2B interactions | 2.73e-04 | 74 | 156 | 5 | int:MZT2B | |
| Interaction | LPGAT1 interactions | 2.73e-04 | 74 | 156 | 5 | int:LPGAT1 | |
| Interaction | IPPK interactions | 2.88e-04 | 116 | 156 | 6 | int:IPPK | |
| Interaction | ERGIC3 interactions | GPR37 FAXDC2 TMEM107 ADGRE2 PIGU CHRNB2 YIPF2 YIPF1 SLC41A1 PLP1 | 3.26e-04 | 340 | 156 | 10 | int:ERGIC3 |
| Interaction | MT-ATP8 interactions | 3.37e-04 | 43 | 156 | 4 | int:MT-ATP8 | |
| Interaction | KCNJ3 interactions | 3.41e-04 | 18 | 156 | 3 | int:KCNJ3 | |
| Interaction | LMBR1 interactions | 3.49e-04 | 78 | 156 | 5 | int:LMBR1 | |
| Interaction | RLN3 interactions | 3.54e-04 | 4 | 156 | 2 | int:RLN3 | |
| Interaction | DYM interactions | 3.93e-04 | 80 | 156 | 5 | int:DYM | |
| Interaction | AVPR2 interactions | 3.94e-04 | 123 | 156 | 6 | int:AVPR2 | |
| Interaction | TTK interactions | 4.05e-04 | 173 | 156 | 7 | int:TTK | |
| Interaction | DERL2 interactions | 4.12e-04 | 124 | 156 | 6 | int:DERL2 | |
| Interaction | TMEM230 interactions | 4.38e-04 | 46 | 156 | 4 | int:TMEM230 | |
| Interaction | ADRB1 interactions | 4.71e-04 | 20 | 156 | 3 | int:ADRB1 | |
| Interaction | ABCA13 interactions | 4.71e-04 | 20 | 156 | 3 | int:ABCA13 | |
| Interaction | BTAF1 interactions | 4.87e-04 | 128 | 156 | 6 | int:BTAF1 | |
| Interaction | SLC10A6 interactions | 4.97e-04 | 179 | 156 | 7 | int:SLC10A6 | |
| Interaction | HTR2C interactions | 5.29e-04 | 130 | 156 | 6 | int:HTR2C | |
| Interaction | IFNLR1 interactions | 5.58e-04 | 49 | 156 | 4 | int:IFNLR1 | |
| Interaction | ATP12A interactions | 5.67e-04 | 183 | 156 | 7 | int:ATP12A | |
| Interaction | SCAMP3 interactions | 5.67e-04 | 183 | 156 | 7 | int:SCAMP3 | |
| Interaction | KCNJ5 interactions | 6.29e-04 | 22 | 156 | 3 | int:KCNJ5 | |
| Interaction | TM9SF1 interactions | 6.51e-04 | 51 | 156 | 4 | int:TM9SF1 | |
| Interaction | ATP1A3 interactions | 6.94e-04 | 247 | 156 | 8 | int:ATP1A3 | |
| Interaction | GPR12 interactions | 7.83e-04 | 93 | 156 | 5 | int:GPR12 | |
| Interaction | SLC1A5 interactions | 7.91e-04 | 252 | 156 | 8 | int:SLC1A5 | |
| Interaction | TMEM208 interactions | 8.09e-04 | 54 | 156 | 4 | int:TMEM208 | |
| Interaction | CNPY4 interactions | 8.17e-04 | 24 | 156 | 3 | int:CNPY4 | |
| Interaction | LEMD2 interactions | 8.22e-04 | 94 | 156 | 5 | int:LEMD2 | |
| Interaction | ATP2B4 interactions | 8.50e-04 | 196 | 156 | 7 | int:ATP2B4 | |
| Interaction | TM9SF3 interactions | 8.73e-04 | 143 | 156 | 6 | int:TM9SF3 | |
| Interaction | ADRB3 interactions | 8.75e-04 | 6 | 156 | 2 | int:ADRB3 | |
| Interaction | GPR152 interactions | 9.02e-04 | 198 | 156 | 7 | int:GPR152 | |
| Interaction | KCNAB1 interactions | 9.23e-04 | 25 | 156 | 3 | int:KCNAB1 | |
| Interaction | NPLOC4 interactions | 9.29e-04 | 199 | 156 | 7 | int:NPLOC4 | |
| Interaction | TMEM126A interactions | 9.92e-04 | 98 | 156 | 5 | int:TMEM126A | |
| Interaction | SSTR3 interactions | GPR37 GRM5 SLC6A9 SLC8A2 SLC8A1 KCNA1 KCNA2 KCNA6 MLC1 SLC20A1 | 9.98e-04 | 393 | 156 | 10 | int:SSTR3 |
| Interaction | TMEM223 interactions | 1.06e-03 | 58 | 156 | 4 | int:TMEM223 | |
| Cytoband | 7q35 | 5.22e-05 | 55 | 169 | 4 | 7q35 | |
| Cytoband | 5q31-q32 | 8.04e-05 | 4 | 169 | 2 | 5q31-q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.07e-04 | 66 | 169 | 4 | chr7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 1.01e-03 | 119 | 169 | 4 | chr6q23 | |
| Cytoband | 11p15.1 | 1.44e-03 | 60 | 169 | 3 | 11p15.1 | |
| Cytoband | 12p13 | 1.73e-03 | 64 | 169 | 3 | 12p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 2.05e-03 | 353 | 169 | 6 | chr12p13 | |
| Cytoband | 1p36.11 | 2.06e-03 | 68 | 169 | 3 | 1p36.11 | |
| Cytoband | 5q35 | 3.24e-03 | 23 | 169 | 2 | 5q35 | |
| Cytoband | 1p21 | 3.53e-03 | 24 | 169 | 2 | 1p21 | |
| Cytoband | 6q23.2 | 3.82e-03 | 25 | 169 | 2 | 6q23.2 | |
| GeneFamily | Adrenoceptors | 5.64e-14 | 9 | 142 | 7 | 169 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.46e-10 | 13 | 142 | 6 | 170 | |
| GeneFamily | Potassium voltage-gated channels | 7.38e-10 | 40 | 142 | 8 | 274 | |
| GeneFamily | Solute carriers | SLC22A25 SLC4A7 SLC5A7 SLCO6A1 SLC6A9 SLC6A13 SLC8A2 SLC9A4 SLC8A1 SLC8A3 SLC30A5 SLC17A9 SLC20A1 SLC16A14 SLC6A5 SLC13A5 SLC41A1 SLC44A3 | 2.06e-09 | 395 | 142 | 18 | 752 |
| GeneFamily | Arginine vasopressin and oxytocin receptors | 3.65e-09 | 4 | 142 | 4 | 259 | |
| GeneFamily | CTAGE family | 7.85e-08 | 15 | 142 | 5 | 907 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.75e-07 | 78 | 142 | 8 | 262 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.49e-07 | 8 | 142 | 4 | 281 | |
| GeneFamily | Relaxin family peptide receptors | 1.89e-06 | 4 | 142 | 3 | 217 | |
| GeneFamily | Dopamine receptors | 4.69e-06 | 5 | 142 | 3 | 181 | |
| GeneFamily | Trace amine receptors | 3.85e-05 | 9 | 142 | 3 | 188 | |
| GeneFamily | Olfactory receptors, family 56 | 3.85e-05 | 9 | 142 | 3 | 167 | |
| GeneFamily | Melatonin receptors | 6.13e-05 | 2 | 142 | 2 | 209 | |
| GeneFamily | ATP binding cassette subfamily C | 1.28e-04 | 13 | 142 | 3 | 807 | |
| GeneFamily | Formyl peptide receptors | 1.83e-04 | 3 | 142 | 2 | 198 | |
| GeneFamily | Secretory carrier membrane proteins | 6.03e-04 | 5 | 142 | 2 | 735 | |
| GeneFamily | Melanocortin receptors | 6.03e-04 | 5 | 142 | 2 | 236 | |
| GeneFamily | Sphingosine 1-phosphate receptors|CD molecules | 6.03e-04 | 5 | 142 | 2 | 206 | |
| GeneFamily | CD molecules|C-X-C motif chemokine receptors | 9.00e-04 | 6 | 142 | 2 | 1094 | |
| GeneFamily | Atypical chemokine receptors | 9.00e-04 | 6 | 142 | 2 | 1090 | |
| GeneFamily | Yip1 domain containing | 1.25e-03 | 7 | 142 | 2 | 105 | |
| GeneFamily | ATP binding cassette subfamily A | 5.24e-03 | 14 | 142 | 2 | 805 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 6.84e-03 | 16 | 142 | 2 | 173 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.51e-02 | 24 | 142 | 2 | 485 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | TEX261 CHRNA6 COL9A1 DRD2 DRD3 HTR1F HTR4 TRHR HTR5A HTR7 AVPR1B AVPR2 MC3R GRID1 GRM5 GRM8 GRPR EDNRA CHRNB2 SLC6A9 SLC6A13 SLC8A2 ADRA1D SLC8A1 SLC8A3 ADRA2A KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 ADRB3 KCNA5 KCNA6 KCNC4 CXCR4 KCNJ2 ABCC8 MTNR1A | 1.90e-16 | 1281 | 167 | 39 | M1884 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DRD4 HTR1D HTR7 GRID1 SSTR5 ADCY7 CHRNB2 SLC8A2 NPHS2 KCNA2 OXTR KCNC4 PROM2 ABCC8 SLC6A5 | 1.51e-07 | 438 | 167 | 15 | M1954 |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | DRD4 HTR1D HTR7 GRID1 SSTR5 ADCY7 CHRNB2 SLC8A2 NPHS2 KCNA2 OXTR KCNC4 PROM2 ABCC8 SLC6A5 | 1.60e-07 | 440 | 167 | 15 | MM832 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | DRD2 LHFPL4 HTR4 GRID1 SSTR5 CHRNB2 SLC8A2 NPHS2 ADRA1A KCNA2 OXTR KCNA5 KCNA7 PROM2 ABCC8 SLC6A5 OTOP1 | 2.60e-07 | 591 | 167 | 17 | M2019 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | DRD2 LHFPL4 HTR4 GRID1 SSTR5 CHRNB2 SLC8A2 NPHS2 ADRA1A KCNA2 OXTR KCNA5 KCNA7 PROM2 ABCC8 SLC6A5 OTOP1 | 3.29e-07 | 601 | 167 | 17 | MM866 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TEX261 ABCC1 SLC4A7 ELOVL5 TMEM63B SCAMP2 ECE1 PIGU S1PR3 ADRB2 SLC30A5 TM9SF2 SLC20A1 SLC41A1 FITM2 SFT2D1 | 7.97e-06 | 681 | 167 | 16 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TEX261 ABCC1 SLC4A7 ELOVL5 TMEM63B SCAMP2 ECE1 PIGU S1PR3 ADRB2 SLC30A5 TM9SF2 SLC20A1 SLC41A1 FITM2 SFT2D1 | 1.18e-05 | 703 | 167 | 16 | MM1055 |
| Coexpression | DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS | 1.36e-05 | 48 | 167 | 5 | M40173 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DRD2 HTR1B HTR1F MBOAT1 HTR7 AVPR1A GRM8 S1PR1 S1PR3 ADCY7 CHRNB2 PROM1 ADRA1D ADRA2A ADRA2B ADRB2 KCNA3 OXTR KCNA7 SLC13A5 | 1.77e-05 | 1074 | 167 | 20 | M1941 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | ABCC3 NPY1R DRD4 HTR7 AVPR1B GRID1 GRM6 GRM7 ADRA1A ADRA2A KCNA1 ADRB1 KCNA3 ADRB3 KCNA5 KCNC4 ABCC8 SLC6A5 OTOP1 PLP1 | 3.01e-05 | 1115 | 167 | 20 | M10371 |
| Coexpression | BENPORATH_SUZ12_TARGETS | NPY1R GPR50 HTR7 GRID1 GRM7 SLC8A3 NPHS2 ADRA1A ADRA2A KCNA1 ADRB1 KCNA3 ADRB3 KCNA5 KCNC4 KCNJ2 ABCC8 SLC6A5 OTOP1 | 3.54e-05 | 1035 | 167 | 19 | M9898 |
| Coexpression | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 | 3.62e-05 | 194 | 167 | 8 | M7281 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 4.33e-05 | 199 | 167 | 8 | M7710 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN | 4.49e-05 | 200 | 167 | 8 | M7303 | |
| Coexpression | BENPORATH_EED_TARGETS | NPY1R DRD4 HTR1B GPR50 HTR7 GRID1 GRM7 SLC8A3 ADRA1A ADRA2A KCNA1 ADRB1 KCNA3 ADRB3 KCNC4 KCNJ2 ABCC8 SLC6A5 OTOP1 | 4.81e-05 | 1059 | 167 | 19 | M7617 |
| Coexpression | BENPORATH_PRC2_TARGETS | NPY1R HTR7 GRID1 GRM7 ADRA1A ADRA2A KCNA1 ADRB1 KCNA3 ADRB3 KCNC4 ABCC8 SLC6A5 OTOP1 | 7.65e-05 | 650 | 167 | 14 | M8448 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DRD3 HTR4 SLC5A7 GPR63 GRM8 ADRA1A KCNA1 ABCB11 SLC13A5 TMC5 | 1.60e-09 | 177 | 169 | 10 | fbead6e56271b1f1d447f89857de444ebe7157b0 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DRD3 HTR4 SLC5A7 GPR63 GRM8 ADRA1A KCNA1 ABCB11 SLC13A5 TMC5 | 1.60e-09 | 177 | 169 | 10 | a25ca82c4bda033ee113f8ecb4a541b22e7a29ca |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL9A1 NPY1R AVPR1A S1PR3 EDNRA ADRA1A ADRA2B ADRB2 KCNA5 KCNC4 | 4.50e-09 | 197 | 169 | 10 | fd65a9b41df618ff2a09d76dcf9f1ca3f3bdf52a |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-08 | 178 | 169 | 9 | b0fc56f583cb3f2977fe2306994c0d478c9a6b1b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-08 | 191 | 169 | 9 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-08 | 191 | 169 | 9 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-08 | 196 | 169 | 9 | 88dc4e3efd7ea07617ecde142ec47cc57608f81b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-07 | 163 | 169 | 8 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-07 | 163 | 169 | 8 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-07 | 179 | 169 | 8 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 183 | 169 | 8 | 421265fa15d5a028cb567bb0904e670473ef102b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-07 | 183 | 169 | 8 | 8d45dff06a199b1369576657f7f9dc0249c5f841 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 189 | 169 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 189 | 169 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 189 | 169 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-07 | 189 | 169 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.82e-07 | 190 | 169 | 8 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 192 | 169 | 8 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.98e-07 | 194 | 169 | 8 | b4f4730a53a63118c02a3692a9c52adfd7201598 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.62e-07 | 196 | 169 | 8 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-07 | 198 | 169 | 8 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.30e-07 | 198 | 169 | 8 | 3222d064b6ecab0caa450a59fc1dc79e26fc6fd5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.66e-07 | 199 | 169 | 8 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.66e-07 | 199 | 169 | 8 | f1723cfd6fbb8c8903a3b167872ec8523e3be250 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.91e-06 | 152 | 169 | 7 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.08e-06 | 154 | 169 | 7 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-06 | 169 | 169 | 7 | 2e15a9317da4017757d184f7cc91bd66b072ac51 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 170 | 169 | 7 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 170 | 169 | 7 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-06 | 170 | 169 | 7 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 175 | 169 | 7 | c1e082538f31b5c98ac63f71dcca4a1211a14708 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 175 | 169 | 7 | 2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 175 | 169 | 7 | c36b4526970db9ccfbe2c70b00961fab9f13b133 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-06 | 175 | 169 | 7 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 169 | 7 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-06 | 177 | 169 | 7 | d731400997afea379f47ae8aa0f82802962b0861 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | 3d6bb3cfe89d60f2f00aead9341f9967e5313763 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-06 | 179 | 169 | 7 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-06 | 180 | 169 | 7 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-06 | 180 | 169 | 7 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.07e-06 | 68 | 169 | 5 | ad6c363d7fb3c436e894db30a544748c5df75a45 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.07e-06 | 68 | 169 | 5 | d97199a8c6afa79bff1600f00c2dbf6286df24a2 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Vip_(ventral_GP_(vGP))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.07e-06 | 68 | 169 | 5 | 82d928f5eefa065d26096a84b0d78f131dcc8c73 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-06 | 182 | 169 | 7 | fe4fb213dc0ca482b0f94097fe1b0a51fc2690e2 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-06 | 183 | 169 | 7 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 6.97e-06 | 185 | 169 | 7 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.00e-06 | 70 | 169 | 5 | 511ca39208a8a0efd24cca47270083d5024e6972 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1-Inhibitory_Gad1Gad2_Htr3a.Phlda1_(Interneuron,__(candidate_CGE-derived_3))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.00e-06 | 70 | 169 | 5 | 0f1dba07a2cd974a25239ae1728cfb007a37954c | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Phlda1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.00e-06 | 70 | 169 | 5 | c579fd093d30a5ee56f7cf1039120d00a6369649 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-06 | 186 | 169 | 7 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-06 | 187 | 169 | 7 | d52f7bc0afcdc366b20d199ab33c4ec60ed22a68 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.75e-06 | 188 | 169 | 7 | 36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 190 | 169 | 7 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-06 | 191 | 169 | 7 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.59e-06 | 191 | 169 | 7 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-06 | 191 | 169 | 7 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-06 | 192 | 169 | 7 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-06 | 192 | 169 | 7 | 5995bae840c0b3f420288f557634d0ae9a12a6ae | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 0208fcd8ea4662f40fc2c072ac220d97823eec12 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 04d47ba7cc1f19f1ffb18d9e68469e75063697cf | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 193 | 169 | 7 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.51e-06 | 194 | 169 | 7 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-05 | 196 | 169 | 7 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 197 | 169 | 7 | d2b2eaa6f7294ff56b84a69c8727c7e0f9fd0466 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-05 | 197 | 169 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 199 | 169 | 7 | bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 199 | 169 | 7 | e751eb67510f8a5842dcfed44134160919cdb713 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.29e-05 | 135 | 169 | 6 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.94e-05 | 145 | 169 | 6 | 78f5f4b96420c7f391e4d32a9ed151ed95fad90b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 148 | 169 | 6 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-05 | 149 | 169 | 6 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-05 | 149 | 169 | 6 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 150 | 169 | 6 | 7a9d6a7ff8000e9a061e1b586e4c258cc91a2a09 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 150 | 169 | 6 | e5b843cb2bc847f6cab4cbec0a2a6a72fac50fee | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.63e-05 | 153 | 169 | 6 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 154 | 169 | 6 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 154 | 169 | 6 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 154 | 169 | 6 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.83e-05 | 155 | 169 | 6 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.95e-05 | 94 | 169 | 5 | 82e9178c848468497295c4cc59c662b9279208a1 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6-Inhibitory_Neuron.Slc17a6-Gad1Gad2.Asb4_(Periventricular_Fiber_System_(Pv))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.95e-05 | 94 | 169 | 5 | be1dcfe287f58d608ccdb47cf9c1d12b5e3aa60d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.95e-05 | 94 | 169 | 5 | 576c37fa53fab679f5e8786f5c798e18998186e9 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 157 | 169 | 6 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-05 | 158 | 169 | 6 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-05 | 159 | 169 | 6 | 4750ba9ca06ed97b18df3c74eeb51d3ac8763f63 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 160 | 169 | 6 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-05 | 161 | 169 | 6 | d1f2e5245c7c247b684f48f9f877e149a3ee7c06 | |
| Computational | Genes in the cancer module 146. | GPR3 NPY1R DRD3 HTR4 HTR7 AVPR1A AVPR1B FPR1 FPR2 GRPR EDNRA ADRA2A ADRA2B ADRB1 ADRB2 OXTR CXCR6 CXCR4 ACKR2 | 1.28e-21 | 102 | 84 | 19 | MODULE_146 |
| Computational | Genes in the cancer module 134. | 1.29e-14 | 30 | 84 | 10 | MODULE_134 | |
| Computational | GPCR signaling pathways (immune and neuro). | NPY1R DRD3 AVPR1A FPR1 FPR2 GRM8 EDNRA ADRA2A ADRA2B ADRB2 CXCR6 CXCR4 | 3.86e-12 | 90 | 84 | 12 | MODULE_375 |
| Computational | Genes in the cancer module 288. | 7.30e-12 | 37 | 84 | 9 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | NPY1R DRD3 AVPR1A FPR1 FPR2 GRM8 EDNRA ADRA2A ADRA2B ADRB2 CXCR6 CXCR4 | 1.82e-10 | 124 | 84 | 12 | MODULE_289 |
| Computational | Genes in the cancer module 27. | NPY1R DRD3 DRD4 HTR4 AVPR1A FPR1 FPR2 GRPR EDNRA CHRNB2 ADRA2A ADRA2B ADRB1 ADRB2 OXTR CXCR6 CXCR4 | 1.54e-09 | 355 | 84 | 17 | MODULE_27 |
| Computational | Membranal receptors. | GPR3 NPY1R DRD3 HTR4 HTR7 AVPR1A AVPR1B FPR1 FPR2 GRPR EDNRA PROM1 ADRA2A ADRA2B ADRB2 OXTR CXCR6 CXCR4 KCNJ2 ACKR2 | 1.85e-09 | 517 | 84 | 20 | MODULE_64 |
| Computational | Genes in the cancer module 41. | TEX261 GPR3 DRD3 HTR4 HTR7 AVPR1B FPR2 GRPR OPRL1 SLC6A9 ADRA1D KCNA5 MLC1 ABCC8 ACKR2 LTC4S | 6.40e-06 | 566 | 84 | 16 | MODULE_41 |
| Computational | Neighborhood of BCL2 | 8.72e-06 | 223 | 84 | 10 | MORF_BCL2 | |
| Computational | Neighborhood of IL13 | 1.33e-05 | 234 | 84 | 10 | MORF_IL13 | |
| Computational | Neighborhood of LMO1 | 5.03e-05 | 52 | 84 | 5 | MORF_LMO1 | |
| Computational | Neighborhood of STK17A | 5.66e-05 | 172 | 84 | 8 | MORF_STK17A | |
| Computational | Neighborhood of JAK3 | 1.01e-04 | 96 | 84 | 6 | MORF_JAK3 | |
| Computational | Neighborhood of MT4 | 1.27e-04 | 247 | 84 | 9 | MORF_MT4 | |
| Computational | Neighborhood of PRKCG | 1.27e-04 | 63 | 84 | 5 | GCM_PRKCG | |
| Computational | Neighborhood of FOSL1 | HTR1B HTR4 HTR7 SCAMP1 FPR2 MC2R ECE1 OPRL1 ADRA1A KCNA5 ABCC8 | 3.02e-04 | 406 | 84 | 11 | MORF_FOSL1 |
| Computational | Neighborhood of MYC | 3.92e-04 | 80 | 84 | 5 | MORF_MYC | |
| Computational | Vesicular transport / synapse genes. | 4.40e-04 | 82 | 84 | 5 | MODULE_274 | |
| Computational | Genes in the cancer module 287. | 6.08e-04 | 50 | 84 | 4 | MODULE_287 | |
| Computational | Genes in the cancer module 12. | TEX261 GPR3 DRD3 HTR4 HTR7 AVPR1B OPRL1 SLC6A9 KCNA5 ABCC8 ASCC2 ACKR2 | 6.66e-04 | 519 | 84 | 12 | MODULE_13 |
| Computational | Neighborhood of BNIP1 | 6.94e-04 | 190 | 84 | 7 | MORF_BNIP1 | |
| Computational | Neighborhood of CDC2L5 | 8.34e-04 | 142 | 84 | 6 | MORF_CDC2L5 | |
| Computational | Neighborhood of PML | 9.31e-04 | 145 | 84 | 6 | MORF_PML | |
| Computational | Neighborhood of LTK | 9.99e-04 | 147 | 84 | 6 | MORF_LTK | |
| Computational | Neighborhood of RAGE | 1.04e-03 | 148 | 84 | 6 | MORF_RAGE | |
| Computational | Porins / transporters. | 1.28e-03 | 211 | 84 | 7 | MODULE_63 | |
| Computational | Neighborhood of SMARCD1 | 1.35e-03 | 105 | 84 | 5 | GCM_SMARCD1 | |
| Computational | Neighborhood of DDX11 | 1.36e-03 | 156 | 84 | 6 | MORF_DDX11 | |
| Computational | Genes in the cancer module 367. | 1.45e-03 | 29 | 84 | 3 | MODULE_367 | |
| Computational | Neighborhood of RING1 | 1.80e-03 | 112 | 84 | 5 | GCM_RING1 | |
| Computational | Neighborhood of FANCG | 1.92e-03 | 167 | 84 | 6 | MORF_FANCG | |
| Computational | Ion channels. | 2.15e-03 | 70 | 84 | 4 | MODULE_316 | |
| Computational | Neighborhood of CASP10 | 2.18e-03 | 117 | 84 | 5 | MORF_CASP10 | |
| Computational | Genes in the cancer module 454. | 2.61e-03 | 10 | 84 | 2 | MODULE_454 | |
| Computational | Neighborhood of FANCC | 3.01e-03 | 126 | 84 | 5 | GCM_FANCC | |
| Computational | Neighborhood of FLT1 | 3.01e-03 | 126 | 84 | 5 | MORF_FLT1 | |
| Computational | Genes in the cancer module 123. | 3.13e-03 | 247 | 84 | 7 | MODULE_123 | |
| Computational | Neighborhood of LCAT | 3.80e-03 | 133 | 84 | 5 | MORF_LCAT | |
| Computational | Neighborhood of HEAB | 3.99e-03 | 83 | 84 | 4 | MORF_HEAB | |
| Computational | Genes in the cancer module 171. | 4.45e-03 | 138 | 84 | 5 | MODULE_171 | |
| Computational | Growth suppressors. | 4.45e-03 | 13 | 84 | 2 | MODULE_407 | |
| Computational | Chemotaxis (chemokines). | 5.16e-03 | 45 | 84 | 3 | MODULE_263 | |
| Computational | Genes in the cancer module 119. | 5.17e-03 | 143 | 84 | 5 | MODULE_119 | |
| Computational | Neighborhood of LTK | 5.49e-03 | 46 | 84 | 3 | GCM_LTK | |
| Drug | NSC95090 | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.49e-24 | 40 | 165 | 16 | CID000003251 |
| Drug | spiroxatrine | DRD2 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.89e-24 | 42 | 165 | 16 | CID000005268 |
| Drug | S-(-)-Lisuride | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 4.36e-24 | 65 | 165 | 18 | CID000003938 |
| Drug | buspirone | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GRM5 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR | 6.03e-24 | 80 | 165 | 19 | CID000002477 |
| Drug | mianserin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 3.48e-23 | 87 | 165 | 19 | CID000004184 |
| Drug | prazosin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 AVPR1A AVPR1B AVPR2 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 MTNR1A MTNR1B HRH4 | 7.23e-23 | 193 | 165 | 24 | CID000004893 |
| Drug | Neomigran | DRD2 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.71e-21 | 48 | 165 | 15 | CID000003066 |
| Drug | ritanserin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 4.21e-21 | 61 | 165 | 16 | CID000005074 |
| Drug | tetradotoxin | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GRM5 GRM6 GRM7 GRM8 EDNRA CHRNB2 OPRL1 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 KCNA2 ADRB2 ADRB3 KCNA6 KCNA7 HRH4 | 4.55e-21 | 428 | 165 | 30 | CID000020382 |
| Drug | methiothepin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 6.09e-21 | 77 | 165 | 17 | CID000004106 |
| Drug | phenoxybenzamine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.02e-20 | 115 | 165 | 19 | CID000004768 |
| Drug | 8-OH-DPAT | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR ABCC8 | 1.44e-20 | 117 | 165 | 19 | CID000001220 |
| Drug | NSC186061 | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.70e-20 | 118 | 165 | 19 | CID000004163 |
| Drug | EEDQ | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A ADCY7 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 7.99e-20 | 72 | 165 | 16 | CID000027833 |
| Drug | idazoxan | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 8.74e-20 | 89 | 165 | 17 | CID000054459 |
| Drug | forskolin from Coleus forskohlii | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 HTR5A HTR7 AVPR1A AVPR1B AVPR2 MC2R MC3R RXFP3 SSTR5 GRM5 GRM6 GRM7 GRM8 S1PR1 S1PR3 ADCY7 EDNRA CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 OXTR SLC20A1 KCNJ2 MTNR1A MTNR1B HRH4 | 9.38e-20 | 1013 | 165 | 41 | CID000003413 |
| Drug | amsonine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.77e-19 | 181 | 165 | 21 | CID000002866 |
| Drug | zotepine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 HRH4 | 3.41e-19 | 49 | 165 | 14 | CID000005736 |
| Drug | SCH 23390 | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 AVPR2 ADCY7 OPRL1 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.60e-19 | 116 | 165 | 18 | CID000005018 |
| Drug | pindolol | DRD2 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.78e-19 | 63 | 165 | 15 | CID000004828 |
| Drug | desipramine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 AVPR1B ADCY7 OPRL1 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 SLC6A5 HRH4 | 3.93e-19 | 188 | 165 | 21 | CID000002995 |
| Drug | 3-isoreserpine | ABCC3 ABCC1 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR7 ABCA13 ABCA9 ADCY7 EDNRA ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 ABCB11 | 4.91e-19 | 190 | 165 | 21 | CID000005052 |
| Drug | haloperidol | ABCC1 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR5A HTR7 GRID1 GRM5 GRM6 GRM7 GRM8 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 KCNA2 ADRB2 ADRB3 ABCC8 | 9.07e-19 | 394 | 165 | 27 | CID000003559 |
| Drug | phentolamine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.44e-18 | 200 | 165 | 21 | CID000005775 |
| Drug | dopamine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GPR37 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 ADCY7 CHRNB2 OPRL1 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 KCNA6 KCNJ2 MTNR1A SLC6A5 MTNR1B HRH4 | 1.64e-18 | 715 | 165 | 34 | CID000000681 |
| Drug | spiperone | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 2.83e-18 | 108 | 165 | 17 | CID000005265 |
| Drug | ketanserin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 3.46e-18 | 131 | 165 | 18 | CID000003822 |
| Drug | cyanopindolol | HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.70e-18 | 57 | 165 | 14 | CID000155346 |
| Drug | GTP[S] | DRD2 DRD3 DRD4 HTR1B HTR1D MCHR1 TRHR AVPR1A AVPR1B AVPR2 FPR1 FPR2 RXFP3 SSTR5 GRM5 OPN1SW GRM6 GRM7 GRM8 GRPR ADCY7 OPRL1 ADRA1A ADRB1 ADRB2 ADRB3 MLC1 KCNJ2 MTNR1A MTNR1B HRH4 | 4.13e-18 | 591 | 165 | 31 | CID000001764 |
| Drug | epinine | DRD2 DRD3 DRD4 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 ACKR2 | 4.75e-18 | 24 | 165 | 11 | CID000004382 |
| Drug | transdihydrolisuride | DRD2 DRD3 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 KCNA5 | 6.68e-18 | 34 | 165 | 12 | CID000005406 |
| Drug | urapidil | HTR1B HTR1D HTR1F HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 6.68e-18 | 34 | 165 | 12 | CID000005639 |
| Drug | ipsapirone | DRD2 HTR1B HTR1D HTR1F HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.05e-17 | 61 | 165 | 14 | CID000056971 |
| Drug | NSC755875 | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 ADCY7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.17e-17 | 165 | 165 | 19 | CID000002215 |
| Drug | amitriptyline | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 ADRB2 ADRB3 HRH4 | 1.18e-17 | 140 | 165 | 18 | CID000002160 |
| Drug | Bromocriptine | 1.26e-17 | 18 | 165 | 10 | DB01200 | |
| Drug | piperoxan | DRD2 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.45e-17 | 26 | 165 | 11 | CID000006040 |
| Drug | Ergot | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A ADRA1D ADRA1A ADRA2A ADRA2B OXTR KCNJ2 | 1.46e-17 | 48 | 165 | 13 | CID000003250 |
| Drug | 6-OHDA | DRD2 DRD3 DRD4 HTR1B HTR1D MCHR1 HTR7 GPR37 SSTR5 GRM5 GRM6 GRM8 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.47e-17 | 255 | 165 | 22 | CID000004624 |
| Drug | hexamethonium | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR4 HTR7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.73e-17 | 143 | 165 | 18 | CID000003604 |
| Drug | citalopram | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 TRHR HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.81e-17 | 120 | 165 | 17 | CID000002771 |
| Drug | WAY-100635 | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B | 1.97e-17 | 49 | 165 | 13 | CID000005684 |
| Drug | clonidine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 P2RY4 KCNJ2 HRH4 | 6.26e-17 | 240 | 165 | 21 | CID000002803 |
| Drug | olanzapine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR5A HTR7 SSTR5 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 6.38e-17 | 129 | 165 | 17 | CID000004585 |
| Drug | clozapine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 HTR5A HTR7 GRM5 CHRNB2 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 SLC6A5 HRH4 | 6.80e-17 | 274 | 165 | 22 | CID000002818 |
| Drug | MK-912 | 8.58e-17 | 14 | 165 | 9 | CID000123679 | |
| Drug | pseudococaine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR4 HTR7 CCRL2 GRID1 GRM5 GRM6 GRM7 GRM8 ADCY7 CHRNB2 OPRL1 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 CXCR4 KCNJ2 SLC6A5 ACKR2 | 1.26e-16 | 570 | 165 | 29 | CID000002826 |
| Drug | SKF 104078 | 2.13e-16 | 15 | 165 | 9 | CID000122295 | |
| Drug | verapamil | ABCC3 ABCC1 CHRNA6 DRD2 HTR7 ABCA13 ABCA9 ADCY7 EDNRA CHRNB2 KCNK18 ADRA1D ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 KCNC4 KCNJ2 ABCB11 | 2.21e-16 | 490 | 165 | 27 | CID000002520 |
| Drug | dopexamine | DRD2 DRD3 DRD4 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 2.34e-16 | 32 | 165 | 11 | CID000055483 |
| Drug | sulpiride | DRD2 DRD3 DRD4 HTR1B HTR1D HTR4 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.30e-16 | 96 | 165 | 15 | CID000005355 |
| Drug | loxapine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 ADRA1A ADRA2A ADRA2B HRH4 | 4.40e-16 | 46 | 165 | 12 | CID000003964 |
| Drug | oxymetazoline | CHRNA6 HTR1B HTR1D HTR1F HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 5.21e-16 | 79 | 165 | 14 | CID000004636 |
| Drug | serotonin | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 AVPR1A AVPR1B ADCY7 CHRNB2 OPRL1 SLC6A13 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 KCNA6 MTNR1A SLC6A5 MTNR1B HRH4 | 5.30e-16 | 554 | 165 | 28 | CID000005202 |
| Drug | ibopamine | DRD2 DRD3 DRD4 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 5.45e-16 | 24 | 165 | 10 | CID000068555 |
| Drug | B-HT 920 | DRD2 DRD3 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 5.87e-16 | 47 | 165 | 12 | CID000005374 |
| Drug | NAN-190 | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADRA1A ADRA2A ADRA2B | 5.87e-16 | 47 | 165 | 12 | CID000004431 |
| Drug | atropine sulfate | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 GRPR ADCY7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 ABCC8 HRH4 | 8.56e-16 | 347 | 165 | 23 | CID000003661 |
| Drug | Pergolide | 1.02e-15 | 17 | 165 | 9 | DB01186 | |
| Drug | imiloxan | 1.02e-15 | 17 | 165 | 9 | CID000133621 | |
| Drug | dihydroergocryptine | DRD2 DRD3 DRD4 TRHR ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.02e-15 | 49 | 165 | 12 | CID000114948 |
| Drug | tramazoline | 1.04e-15 | 11 | 165 | 8 | CID000005524 | |
| Drug | pimozide | DRD2 DRD3 DRD4 HTR1B HTR1D HTR7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 KCNA10 ABCC8 | 1.13e-15 | 127 | 165 | 16 | CID000016362 |
| Drug | alpha-methyl-p-tyrosine | DRD2 DRD3 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 KCNA6 | 1.38e-15 | 66 | 165 | 13 | CID000003125 |
| Drug | Clozapine | 1.46e-15 | 26 | 165 | 10 | DB00363 | |
| Drug | Quetiapine | 1.46e-15 | 26 | 165 | 10 | DB01224 | |
| Drug | T15550 | 1.46e-15 | 26 | 165 | 10 | CID000005454 | |
| Drug | tyramine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR7 TAAR2 ADCY7 EDNRA ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 1.65e-15 | 130 | 165 | 16 | CID000005610 |
| Drug | amphetamine | DRD2 DRD3 DRD4 HTR1B HTR1D MCHR1 GPR37 GRM5 GRM6 GRM7 GRM8 ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 SLC6A5 | 1.89e-15 | 284 | 165 | 21 | CID000003007 |
| Drug | acetylcholine | CHRNA6 DRD2 DRD3 DRD4 HTR1B HTR1D HTR4 HTR7 SLC5A7 ADCY7 EDNRA CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 KCNA2 ADRB2 ADRB3 ABCC8 HRH4 | 2.01e-15 | 361 | 165 | 23 | CID000000187 |
| Drug | adenosine 3',5'-cyclic phosphate | DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR7 AVPR1A AVPR1B AVPR2 SCAMP1 MC2R MC3R GRM5 GRM6 GRM7 GRM8 ADCY7 EDNRA OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 KCNC4 SLC20A1 MTNR1A MTNR1B HRH4 | 2.09e-15 | 907 | 165 | 34 | CID000000274 |
| Drug | NSC169490 | 2.30e-15 | 27 | 165 | 10 | CID004210613 | |
| Drug | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine | DRD2 DRD3 DRD4 HTR1B HTR1D SLC6A13 ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 SLC6A5 | 2.56e-15 | 69 | 165 | 13 | CID000003172 |
| Drug | roxindole | 3.56e-15 | 28 | 165 | 10 | CID000219050 | |
| Drug | mirtazapine | DRD2 DRD3 HTR1B HTR1D HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 3.69e-15 | 54 | 165 | 12 | CID000004205 |
| Drug | benalfocin | 3.84e-15 | 19 | 165 | 9 | CID000123981 | |
| Drug | AC1L1CBF | DRD2 DRD3 DRD4 HTR1B HTR1D MCHR1 TRHR HTR5A AVPR1A AVPR1B MC2R SSTR5 ADCY7 EDNRA OPRL1 ADRA1A ADRB1 ADRB2 ADRB3 MTNR1A MTNR1B LTC4S | 4.88e-15 | 336 | 165 | 22 | CID000001822 |
| Drug | BMY 7378 | HTR1B HTR1D HTR7 S1PR3 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 5.41e-15 | 41 | 165 | 11 | CID000002419 |
| Drug | Saphris | DRD2 DRD3 DRD4 HTR1B HTR1D HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B | 5.41e-15 | 41 | 165 | 11 | CID000163091 |
| Drug | chlorpromazine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR4 HTR5A HTR7 ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 5.44e-15 | 197 | 165 | 18 | CID000002726 |
| Drug | sotalol | ADRA1D ADRA1A ADRA2A ADRA2B KCNA1 ADRB1 KCNA2 ADRB2 KCNA3 ADRB3 KCNA5 KCNA6 KCNJ2 | 5.58e-15 | 73 | 165 | 13 | CID000005253 |
| Drug | LY 171555 | DRD2 DRD3 DRD4 HTR1B HTR1D OPN1SW ADCY7 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 6.83e-15 | 142 | 165 | 16 | CID000001257 |
| Drug | midaglizole | 6.94e-15 | 20 | 165 | 9 | CID000068864 | |
| Drug | MHPG | DRD2 DRD3 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 7.47e-15 | 57 | 165 | 12 | CID000010805 |
| Drug | AC1L1G8Z | DRD2 DRD3 HTR1B HTR1D HTR1F HTR7 ADRA1D ADRA1A ADRA2A ADRA2B | 8.04e-15 | 30 | 165 | 10 | CID000003581 |
| Drug | clorgyline | DRD2 DRD3 DRD4 HTR1B HTR1D HTR7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 8.09e-15 | 75 | 165 | 13 | CID000004380 |
| Drug | mesulergine | 1.18e-14 | 31 | 165 | 10 | CID000068848 | |
| Drug | EN-1530 | CHRNA6 DRD2 NPY1R DRD3 DRD4 GRM5 GRM6 GRM7 GRM8 ADCY7 CHRNB2 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 1.56e-14 | 278 | 165 | 20 | CID000004425 |
| Drug | thioridazine | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR5A HTR7 ADRA1D ADRA1A ADRA2A ADRA2B HRH4 | 1.64e-14 | 79 | 165 | 13 | CID000005452 |
| Drug | deriglidole | 1.86e-14 | 14 | 165 | 8 | CID000065945 | |
| Drug | 3-hydroxy-4-methoxycinnamic acid | 1.86e-14 | 14 | 165 | 8 | CID000092126 | |
| Drug | iodocyanopindolol | HTR1B HTR1D ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 2.43e-14 | 33 | 165 | 10 | CID000068618 |
| Drug | tetralin | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F MCHR1 HTR4 HTR5A HTR7 MTNR1A MTNR1B | 2.71e-14 | 63 | 165 | 12 | CID000008404 |
| Drug | aganodine | 3.31e-14 | 23 | 165 | 9 | CID000176878 | |
| Drug | alprenolol | HTR1B TRHR HTR5A ADCY7 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 ACKR2 | 3.32e-14 | 64 | 165 | 12 | CID000002119 |
| Drug | Cabergoline | 3.95e-14 | 15 | 165 | 8 | DB00248 | |
| Drug | MAMP | DRD2 DRD3 DRD4 HTR1B HTR1D GRM5 OPRL1 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 P2RY4 HRH4 | 4.57e-14 | 160 | 165 | 16 | CID000001206 |
| Drug | brimonidine | CHRNA6 HTR1B HTR1D ADCY7 CHRNB2 ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 HRH4 | 5.19e-14 | 86 | 165 | 13 | CID000002435 |
| Drug | reboxetine | DRD2 DRD3 DRD4 HTR1B HTR1D ADRA1D ADRA1A ADRA2A ADRA2B ADRB1 ADRB2 ADRB3 | 5.95e-14 | 67 | 165 | 12 | CID000065856 |
| Drug | AC1Q7BEJ | DRD2 DRD3 DRD4 HTR1B HTR1D HTR1F HTR7 ADCY7 ADRA1A ADRA2A ADRA2B | 6.05e-14 | 50 | 165 | 11 | CID000001224 |
| Disease | Bipolar Disorder | CHRNA6 DRD2 DRD3 DRD4 HTR1B MCHR1 HTR4 GPR50 HTR5A AVPR1B ABCA13 MC2R GRID1 SSTR5 GRM5 GRM7 S1PR1 SLC6A13 ADRA1A ADRB2 MLC1 | 8.70e-14 | 477 | 154 | 21 | C0005586 |
| Disease | Depressive disorder | CHRNA6 DRD2 NPY1R DRD3 DRD4 HTR1B HTR1D MCHR1 HTR4 HTR7 GRID1 GRM7 GRPR ADCY7 ADRA2A ADRB1 OXTR | 2.28e-13 | 289 | 154 | 17 | C0011581 |
| Disease | Mood Disorders | DRD2 DRD3 DRD4 HTR1B MCHR1 HTR4 GPR50 HTR5A HTR7 AVPR1B SLC5A7 ADCY7 ADRA2A ADRB1 | 2.87e-13 | 168 | 154 | 14 | C0525045 |
| Disease | Schizophrenia | DRD2 NPY1R DRD3 DRD4 HTR1F MCHR1 HTR4 GPR50 HTR5A HTR7 AVPR1A ABCA13 GRID1 GRM5 GRM7 GRM8 ADCY7 CHRNB2 SLC6A9 ADRA1A ADRA2A OXTR MLC1 MTNR1A SLC6A5 PLP1 | 8.73e-13 | 883 | 154 | 26 | C0036341 |
| Disease | hypertension (is_implicated_in) | DRD2 TRHR AVPR1A ECE1 EDNRA SLC8A1 ADRA1A ADRA2B ADRB1 ADRB2 ADRB3 ABCC8 | 1.90e-12 | 121 | 154 | 12 | DOID:10763 (is_implicated_in) |
| Disease | Mental Depression | CHRNA6 DRD2 DRD3 DRD4 HTR1B MCHR1 HTR4 HTR7 GRID1 GRM7 GRPR ADCY7 ADRA2A ADRB1 OXTR | 5.92e-12 | 254 | 154 | 15 | C0011570 |
| Disease | Unipolar Depression | DRD2 NPY1R DRD3 DRD4 HTR1B HTR7 SLC5A7 SSTR5 GRM5 GRM7 ADCY7 PROM1 SLC6A13 ADRA1A OXTR | 7.82e-12 | 259 | 154 | 15 | C0041696 |
| Disease | Major Depressive Disorder | DRD2 DRD3 DRD4 HTR1B SLC5A7 SSTR5 GRM5 GRM7 ADCY7 PROM1 SLC6A13 ADRA1A OXTR | 5.44e-10 | 243 | 154 | 13 | C1269683 |
| Disease | Attention Deficit Disorder | 1.28e-09 | 22 | 154 | 6 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.28e-09 | 22 | 154 | 6 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 2.28e-09 | 24 | 154 | 6 | C1263846 | |
| Disease | hypertension (biomarker_via_orthology) | HTR1B AVPR1A ECE1 EDNRA SLC8A1 ADRA1A ADRA2A FADS1 ADRB1 ADRB2 OXTR KCNA5 | 2.94e-09 | 227 | 154 | 12 | DOID:10763 (biomarker_via_orthology) |
| Disease | epilepsy (implicated_via_orthology) | GRM8 KCNK18 KCNA1 KCNA2 KCNA3 KCNA5 KCNA6 KCNA7 KCNA10 SLC13A5 | 1.55e-08 | 163 | 154 | 10 | DOID:1826 (implicated_via_orthology) |
| Disease | hypertension (implicated_via_orthology) | 3.86e-07 | 128 | 154 | 8 | DOID:10763 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 9.27e-07 | 195 | 154 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 1.24e-06 | 261 | 154 | 10 | C0004352 | |
| Disease | Seizures, Focal | 1.28e-06 | 104 | 154 | 7 | C0751495 | |
| Disease | Myoclonic Seizures | 1.28e-06 | 104 | 154 | 7 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.28e-06 | 104 | 154 | 7 | C0494475 | |
| Disease | Alcoholic Intoxication, Chronic | 1.57e-06 | 268 | 154 | 10 | C0001973 | |
| Disease | Amphetamine-Related Disorders | 2.74e-06 | 75 | 154 | 6 | C0236733 | |
| Disease | Amphetamine Abuse | 2.74e-06 | 75 | 154 | 6 | C0236807 | |
| Disease | Amphetamine Addiction | 2.74e-06 | 75 | 154 | 6 | C0236804 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.24e-06 | 20 | 154 | 4 | DOID:1094 (is_implicated_in) | |
| Disease | Anxiety States, Neurotic | 3.34e-06 | 44 | 154 | 5 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 3.34e-06 | 44 | 154 | 5 | C1279420 | |
| Disease | Anxiety Disorders | 3.34e-06 | 44 | 154 | 5 | C0003469 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 3.99e-06 | 21 | 154 | 4 | DOID:11612 (biomarker_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.85e-06 | 22 | 154 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Congenital adrenal hyperplasia | 1.14e-05 | 9 | 154 | 3 | C0001627 | |
| Disease | Recurrent depression | 1.14e-05 | 9 | 154 | 3 | C0221480 | |
| Disease | Generalized seizures | 1.54e-05 | 101 | 154 | 6 | C0234533 | |
| Disease | Clonic Seizures | 1.54e-05 | 101 | 154 | 6 | C0234535 | |
| Disease | Convulsive Seizures | 1.54e-05 | 101 | 154 | 6 | C0751494 | |
| Disease | Seizures, Sensory | 1.54e-05 | 101 | 154 | 6 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.54e-05 | 101 | 154 | 6 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.54e-05 | 101 | 154 | 6 | C0751123 | |
| Disease | Complex partial seizures | 1.54e-05 | 101 | 154 | 6 | C0149958 | |
| Disease | Single Seizure | 1.54e-05 | 101 | 154 | 6 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.54e-05 | 101 | 154 | 6 | C3495874 | |
| Disease | Visual seizure | 1.54e-05 | 101 | 154 | 6 | C0270824 | |
| Disease | Epileptic drop attack | 1.54e-05 | 101 | 154 | 6 | C0270846 | |
| Disease | Vertiginous seizure | 1.54e-05 | 101 | 154 | 6 | C0422855 | |
| Disease | Gustatory seizure | 1.54e-05 | 101 | 154 | 6 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.54e-05 | 101 | 154 | 6 | C0422850 | |
| Disease | Olfactory seizure | 1.54e-05 | 101 | 154 | 6 | C0422853 | |
| Disease | Seizures, Auditory | 1.54e-05 | 101 | 154 | 6 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.54e-05 | 101 | 154 | 6 | C4505436 | |
| Disease | Jacksonian Seizure | 1.54e-05 | 101 | 154 | 6 | C0022333 | |
| Disease | Epileptic Seizures | 1.54e-05 | 101 | 154 | 6 | C4317109 | |
| Disease | Colorectal Neoplasms | 1.61e-05 | 277 | 154 | 9 | C0009404 | |
| Disease | Absence Seizures | 1.63e-05 | 102 | 154 | 6 | C4316903 | |
| Disease | Convulsions | 1.63e-05 | 102 | 154 | 6 | C4048158 | |
| Disease | Tonic Seizures | 1.63e-05 | 102 | 154 | 6 | C0270844 | |
| Disease | monocyte percentage of leukocytes | ZDHHC18 HTR4 UBE3B CCRL2 SCAMP2 S1PR1 S1PR3 ADRA2B FADS1 ADRB2 KCNA3 CXCR4 ACKR2 LTC4S | 3.13e-05 | 731 | 154 | 14 | EFO_0007989 |
| Disease | Cocaine Abuse | 5.63e-05 | 127 | 154 | 6 | C0009171 | |
| Disease | congestive heart failure (implicated_via_orthology) | 6.22e-05 | 41 | 154 | 4 | DOID:6000 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 6.57e-05 | 190 | 154 | 7 | C0020538 | |
| Disease | Disruptive, Impulse Control, and Conduct Disorders | 8.09e-05 | 3 | 154 | 2 | C0021122 | |
| Disease | Intermittent Explosive Disorder | 8.09e-05 | 3 | 154 | 2 | C0021776 | |
| Disease | Autism Spectrum Disorders | 8.50e-05 | 85 | 154 | 5 | C1510586 | |
| Disease | obesity (is_implicated_in) | 1.18e-04 | 91 | 154 | 5 | DOID:9970 (is_implicated_in) | |
| Disease | obesity (biomarker_via_orthology) | 1.26e-04 | 147 | 154 | 6 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Seizures | 1.55e-04 | 218 | 154 | 7 | C0036572 | |
| Disease | Migraine with or without aura, susceptibility to | 1.61e-04 | 4 | 154 | 2 | cv:CN300932 | |
| Disease | response to hydroxyurea | 1.61e-04 | 4 | 154 | 2 | GO_0072710 | |
| Disease | levulinate 4-oxovalerate measurement | 1.61e-04 | 4 | 154 | 2 | EFO_0021024 | |
| Disease | Migraine | 1.61e-04 | 4 | 154 | 2 | cv:C0149931 | |
| Disease | conduct disorder (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:12995 (is_implicated_in) | |
| Disease | Hypotension | 1.71e-04 | 53 | 154 | 4 | C0020649 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.83e-04 | 100 | 154 | 5 | DOID:1824 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.84e-04 | 54 | 154 | 4 | DOID:6432 (implicated_via_orthology) | |
| Disease | depressive disorder (implicated_via_orthology) | 2.00e-04 | 22 | 154 | 3 | DOID:1596 (implicated_via_orthology) | |
| Disease | Withdrawal Symptoms | 2.43e-04 | 58 | 154 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.43e-04 | 58 | 154 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.43e-04 | 58 | 154 | 4 | C0038587 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 2.60e-04 | 24 | 154 | 3 | DOID:1184 (biomarker_via_orthology) | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 2.68e-04 | 5 | 154 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | heroin dependence (biomarker_via_orthology) | 2.68e-04 | 5 | 154 | 2 | DOID:9976 (biomarker_via_orthology) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.87e-04 | 171 | 154 | 6 | DOID:9352 (is_implicated_in) | |
| Disease | Cardiac Arrhythmia | 2.95e-04 | 25 | 154 | 3 | C0003811 | |
| Disease | acute kidney failure (implicated_via_orthology) | 3.72e-04 | 27 | 154 | 3 | DOID:3021 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 4.00e-04 | 66 | 154 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | myocardial infarction (implicated_via_orthology) | 4.00e-04 | 66 | 154 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | brain edema (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:4724 (implicated_via_orthology) | |
| Disease | Atrial fibrillation | 4.00e-04 | 6 | 154 | 2 | cv:C0004238 | |
| Disease | Fever, Diarrhea, response to sulfasalazine | 4.00e-04 | 6 | 154 | 2 | EFO_0008324, HP_0001945, HP_0002014 | |
| Disease | Alzheimer's disease (is_marker_for) | 4.20e-04 | 257 | 154 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Grand Mal Status Epilepticus | 4.24e-04 | 67 | 154 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.24e-04 | 67 | 154 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 4.24e-04 | 67 | 154 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 4.24e-04 | 67 | 154 | 4 | C0751523 | |
| Disease | Petit mal status | 4.24e-04 | 67 | 154 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 4.24e-04 | 67 | 154 | 4 | C0393734 | |
| Disease | Status Epilepticus | 4.48e-04 | 68 | 154 | 4 | C0038220 | |
| Disease | Parkinsonism (implicated_via_orthology) | 4.61e-04 | 29 | 154 | 3 | DOID:0080855 (implicated_via_orthology) | |
| Disease | electrocardiography | MBOAT1 FPR1 PROM1 SLC8A1 ADRB1 KCNA2 KCNA3 KCNA7 KCNJ2 SLC41A1 | 4.91e-04 | 530 | 154 | 10 | EFO_0004327 |
| Disease | Subwakefullness Syndrome | 5.59e-04 | 7 | 154 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 5.59e-04 | 7 | 154 | 2 | C0751510 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAAALVVAFFVLWFP | 251 | O00590 | |
| GVFTLCWLPFFLANV | 331 | P08588 | |
| VIFYIAFCLLWPLVV | 1081 | Q6ZRH7 | |
| GAFIVCWLPFFIISL | 321 | P28222 | |
| TFTLCWLPFFIVNIV | 281 | P07550 | |
| AVSNLCFLLTLPFWA | 81 | O00421 | |
| TVILILAFFACWLPY | 241 | P61073 | |
| ADLVFVCTLPFWAYA | 76 | O00574 | |
| CAAVIGFFVVLLFLW | 46 | Q8IX94 | |
| CAAVIGFFVVLLFLW | 46 | Q86UF2 | |
| CAAVIGFFVVLLFLW | 46 | P0CG41 | |
| CAAVIGFFVVLLFLW | 46 | A4FU28 | |
| CAAVIGFFVVLLFLW | 46 | A4D2H0 | |
| AFVICWLPFFVKELV | 301 | P30939 | |
| FLVFLAFCVWLTLPG | 6 | Q9UHX3 | |
| CIVVASFVLCWLPFF | 236 | Q9Y672 | |
| SFVLCWLPFFTEREQ | 241 | Q9Y672 | |
| DLTFSFLVFWFCLPV | 11 | Q0VDE8 | |
| AFLEWTLCLLSPFAF | 356 | Q8IUA7 | |
| IVVGCFVLCWLPFFL | 276 | P35348 | |
| LWAFLDIFPLACQTF | 256 | Q9H1I8 | |
| IWQEALSCLQFVLPF | 176 | O00270 | |
| LVSAFFIFWSPFNVV | 261 | O75388 | |
| FLAEFFWPCILFVIL | 26 | Q86UQ4 | |
| FWPCILFVILTVLRF | 31 | Q86UQ4 | |
| FSWKLSLVILCFFPF | 896 | O95342 | |
| ALPIFFLGVFVWAVF | 11 | Q5VUY2 | |
| FVLAVVIGVFVLCWF | 371 | P18089 | |
| KTVFCLVVIFALCWF | 306 | P25101 | |
| CAWEQVPFFLFIVFV | 121 | P51828 | |
| FTLCWLPFFLANVLR | 301 | P13945 | |
| VFACFATPAVTWRLL | 356 | O95199 | |
| WVKSVVCFVPLLFIY | 21 | Q8NGY2 | |
| VLIIFWFLCVVCAIV | 136 | O15438 | |
| VIFCLAFVLSWLFFG | 86 | P63252 | |
| CDFFPERWFHIVFVL | 81 | Q9Y3D8 | |
| AIFWFDLRSISFPAC | 86 | Q8NGH8 | |
| PFFIVETLCIIWFSF | 221 | P16389 | |
| FPFFEAICWFVAKNL | 396 | Q6ZMT4 | |
| CAAAILPFWETQLDF | 296 | Q7Z418 | |
| WFSFELVVRFFACPS | 231 | Q09470 | |
| TCIIWLAFVPIYFGS | 781 | P41594 | |
| LYLSAAVIWPVFCFD | 241 | A6NDP7 | |
| TCFLLEVPEANWAFL | 216 | Q8IU57 | |
| AVTNVLIFFWCLAFL | 376 | Q8NC56 | |
| WFLLDNYIPTFICSV | 26 | Q9NYP7 | |
| VVASFFICWFPFQLV | 246 | P25090 | |
| FICWFPFQLVALLGT | 251 | P25090 | |
| VFVIFAICWAPLNCI | 256 | P49286 | |
| VIFLLFAVCWCPINV | 241 | Q13585 | |
| CLLFIPIQWLFFAAS | 91 | Q8N5G2 | |
| CSEYFPLFLATLWVA | 56 | Q16873 | |
| VVTLFFGPCTFIYVW | 246 | Q96R72 | |
| VVTLFFAPCVFIYVW | 246 | Q8NH42 | |
| LFIIMTFPFSIWFCV | 111 | Q9NP85 | |
| FSDPFFVVETLCIIW | 291 | P22001 | |
| WLIFTNCIFFCPVAF | 751 | Q9BXB1 | |
| FAEAVNFCTVDWLPL | 596 | Q9UGL1 | |
| VLAFIVCWTPFFFVQ | 281 | P30559 | |
| CWVGAFLSVLFPTIV | 146 | Q8NGM8 | |
| CIIWLAFIPIFFGTA | 791 | O00222 | |
| AIGVLWAIFTICFAI | 21 | Q7Z7J7 | |
| ICLSFFLLSSWDFIP | 241 | Q9H490 | |
| VVGAFLLCWTPFFVV | 351 | P21917 | |
| VVLGAFAACWLPFTV | 251 | P46089 | |
| CTQFWFFARIKPTIF | 31 | A8MZH6 | |
| FWLPIGCAAFVVVCI | 141 | Q9Y6W8 | |
| AIFWFDLRSISFPAC | 86 | P0C7T3 | |
| WPFGTEICKFVRFLF | 101 | P51582 | |
| AFAVCWLPLTIFNTV | 271 | P25929 | |
| WFTFELVLRFVVCPS | 281 | Q16322 | |
| IAAFLFLCNISLWIP | 546 | Q7RTM1 | |
| WILFFIGAIQVPCLF | 76 | Q96IV6 | |
| IGAIQVPCLFFWSFN | 81 | Q96IV6 | |
| VPCLFFWSFNGLLLV | 86 | Q96IV6 | |
| VFLWVFIIVCVFGTA | 466 | Q15825 | |
| ITNCSPLVVKFRWFF | 1191 | Q4G0P3 | |
| TTCIIWLAFVPIFFG | 791 | O15303 | |
| ADPFFIVETTCVIWF | 321 | P22460 | |
| DPFFLVETLCIVWFT | 261 | P17658 | |
| NDPFFVVETLCICWF | 206 | Q96RP8 | |
| WDFLIIFFCLPLVIF | 306 | O15354 | |
| FVAMFWPLIPQFVCN | 406 | Q9NZS9 | |
| AWTFCLLLPFIALTN | 66 | Q8N6M3 | |
| VLVFVGLFAFCWLPN | 266 | P30550 | |
| TQFFPTLLLWCFSAL | 476 | Q5T3F8 | |
| ILGAFIICWLPFFVV | 306 | P28221 | |
| IGVFVLCWIPFFLTE | 291 | P47898 | |
| CWAPFFVTNIVDPFI | 271 | Q13639 | |
| WVFGTSFLPFLLCAV | 151 | O60427 | |
| FVVCQLVALFAAFWF | 36 | Q6ZNC8 | |
| ILLGVFIFCWAPFFL | 246 | P41968 | |
| FIFCWAPFFLHLVLI | 251 | P41968 | |
| TAIAICLVFFVCWAP | 326 | Q99705 | |
| SLFAPFDFAVWACIA | 556 | Q9ULK0 | |
| TTCIVWLAFIPIFFG | 796 | Q14831 | |
| ILILFAVFIVCWAPF | 316 | Q9BZJ6 | |
| FQVWAVPLLLVAFFA | 561 | Q8N4M1 | |
| KIPVFFFVCSFLEPW | 6 | P20849 | |
| FFVCSFLEPWASAAV | 11 | P20849 | |
| AIVLGVFIICWLPFF | 376 | P14416 | |
| FFLGFAQVWCSVRTP | 706 | P42892 | |
| SAPCFVFFLFSRWLA | 266 | Q6T423 | |
| CFLSFVRFASTIPFW | 351 | Q6T423 | |
| ICFFLLVILWFSRDP | 321 | Q86YT5 | |
| VLSVFIACWAPLFIL | 261 | P21453 | |
| VFIACWSPLFILFLI | 251 | Q99500 | |
| VGCAVFCALIVWFFV | 236 | Q8WUM9 | |
| AVWVLAFAVSCPLLF | 156 | P35462 | |
| VSEFLLICFPNFQSW | 16 | Q8NGH5 | |
| WGPVFAICIFLFSFI | 211 | P41146 | |
| TWFLFIFCFIVPLSL | 201 | P03999 | |
| FTWVCTPFLVALCTF | 551 | P33527 | |
| VFAVCWAPYSLFTIV | 311 | Q9H3N8 | |
| LQFTPGFWLTLCEFF | 1186 | A6NKG5 | |
| VVLSFFLCWLPNQAL | 331 | Q9NSD7 | |
| QLFCIFVGLWISVPF | 191 | Q9GZV3 | |
| LIFGSWCVSVFFPAL | 61 | Q9NYV8 | |
| WCVSVFFPALFATEK | 66 | Q9NYV8 | |
| LLCAIFFLFLIVSVW | 236 | P59544 | |
| LLAFCWSVPALFSFG | 151 | Q9P1P4 | |
| IPDVLFWCVILFFTT | 821 | Q9Y6M7 | |
| FLSSPFQENWFLLFC | 291 | P34981 | |
| QNWVLLCFLLFFIPN | 196 | Q96RI9 | |
| WAFVTPTILTFILCF | 681 | Q9Y345 | |
| LPCISVWNVFLLANF | 376 | Q7RTX9 | |
| VAAAFFLCWSPYQVV | 246 | P21462 | |
| LVFFVCWLPENVFIS | 266 | Q99527 | |
| VFLCSYIIDPLNLFW | 781 | O43490 | |
| AFCQIWRAISVFALF | 391 | Q6AI14 | |
| FVWVIAFITCFGNLF | 421 | Q8WXD0 | |
| FFIVFSDAICWIPVF | 641 | Q8WXD0 | |
| INFLFAAVVAWCTLI | 316 | Q86UG4 | |
| AACSFFILLSWLPTF | 251 | Q9BYT1 | |
| LSILWFLLFTPCSFV | 186 | O15126 | |
| LSILWFLIFTPCAFL | 186 | O15127 | |
| VCAFFVALLPVWVVL | 291 | Q8IVJ1 | |
| SDFIPVAWLIFLCVV | 176 | Q96LA9 | |
| LVVVLVFAGCWLPFF | 251 | P35346 | |
| VFAGCWLPFFTVNIV | 256 | P35346 | |
| CNFVVLVSWVFGFLF | 141 | Q8NGU2 | |
| LFLWIFVFVCVFGTI | 461 | P17787 | |
| FFFLCPNLWAMPVQI | 431 | Q09428 | |
| FLAWASAFCPDVRFV | 211 | Q6UX72 | |
| IIVGAFTVCWLPFFL | 331 | P34969 | |
| IQWAVAFCPNALFIL | 166 | A8MXE2 | |
| LAVVIGVFVVCWFPF | 391 | P08913 | |
| LTILLGVFIFCWAPF | 221 | Q01718 | |
| AIVVGVFVLCWFPFF | 351 | P25100 | |
| WFAICFVCGVFFSIL | 36 | Q8WV19 | |
| LGIPAWCSYVFFVIA | 181 | Q9H1E5 | |
| KWFFQCFLDRTPFTL | 266 | Q92738 | |
| IVLAYIACWAPFFSV | 286 | P47901 | |
| YGPFWICATLVFAIA | 121 | Q9Y548 | |
| FWFCLAWCTFFLIPS | 781 | Q8N271 | |
| AWCTFFLIPSIIFAV | 786 | Q8N271 | |
| WLFLTPAVCTATFLF | 496 | Q9NSD5 | |
| WYIFVFCSALPAVTE | 111 | Q6UX40 | |
| VGFVLLWAFSCFIFV | 471 | Q8NE00 | |
| FFIVFTDALCWIPIF | 631 | Q9HBX9 | |
| FFQICWRFVSPAIIF | 571 | P48067 | |
| IVIGVFLLCWFPCFF | 266 | Q9P1P5 | |
| FLLCWFPCFFTILLD | 271 | Q9P1P5 | |
| FCLWIIPFAFFVSLS | 131 | Q6UWH6 | |
| IVTAYIVCWAPFFII | 296 | P37288 | |
| QFLWGVPLIRIFFCD | 386 | Q7Z3V4 | |
| LWFCISVPLTFIGAY | 476 | Q99805 | |
| FTPWFVPSLCVSFQF | 2471 | Q7Z7G8 | |
| FGWFIADPLCSLFIA | 616 | Q8TAD4 | |
| IYAQTLVWIGIFFCP | 781 | Q6UXY8 | |
| LIACPVLWVIFAFSA | 131 | Q9NYZ1 | |
| LYGPFWICATLAFVL | 121 | Q9BWQ6 | |
| PESVVRFFLWFCFLL | 6 | Q5T742 | |
| PASVLELVICFFSIW | 276 | Q9NUE0 | |
| IVVVYVLCWAPFFLV | 276 | P30518 | |
| WFTLEFLVRIVCCPD | 291 | Q03721 | |
| TFFWILVACFPSAIA | 231 | Q15049 | |
| FVVFVLFAICWAPLN | 241 | P48039 | |
| EVWEGLLTFFFFPIC | 231 | P32418 | |
| FFPICVVFAWVADRR | 241 | P32418 | |
| VWEALLTLVFFPVCV | 226 | Q9UPR5 | |
| VWEGLLTLFFFPVCV | 231 | P57103 | |
| LTLFFFPVCVLLAWV | 236 | P57103 | |
| VVWLLVFACSAVPVY | 161 | P60201 |